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A V ANT PROPOS 
Ce projet mis en avant par un groupe de recherches de l' UQAM vise à évaluer le 
dosage des rétinoïdes par la chromatographie liquide à haute performance (CLHP) et il 
est repris par les équipes de recherche de professeur Breau et de professeur Tra du 
département de chimie de l'UQAM. 
Plus précisément, l'objectif de mon projet était l'analyse au mveau de trace le 
tout-trans acide rétinoïque (ttAR) et ses métabolites dans un milieu physiologique 
(milieux de culture de cellules P 19 de carcinome embryonnaire de souris) . Bien que 
les résultats n'aient pas atteint le niveau attendu et que certaines limites 
expérimentales aient été rencontrées, cette étude a pennis la mise sur pied d'un 
protocole de quantification au niveau de trace par la méthode sensible de CLHP-ESI-
SM/SM et aussi un protocole d'extraction optimisé dans un milieu physiologique 
simulé. Ce protocole pourra être utilisé pour étudier l'effet de concentration de l'acide 
rétinoïque sur sa voie métabolique et les anomalies résultant d'un manque ou d'un 
excès de rétinoïde qui ont été observées chez les animaux ou chez l'homme. Cette 
méthode fournirait une sensibilité nécessaire pour la quantification de l' AR afin 
élucider la fonction de l 'AR dans la neurogénèse, la morphogénèse et la contribution 
des altérations de l'homéostasie de l 'AR telles que celles observées dans la maladie 
d'Alzheimer, le diabète du type 2, l'obésité et le cancer. 
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RÉSUMÉ 
L'acide tout-trans rétinoïque (ttAR) est un métabolite actif de la vitamine A qui a de 
nombreuses fonctions physiologiques importantes . Le ttAR contrôle la prolifération et 
la différenciation cellulaire, il est essentiel pour le développement et la croissance des 
organismes. Il agit sur l 'expression génique. 
Le ttAR a plusieurs propriétés pharmacologiques et physiologiques utiles en 
dermatologie et dans le traitement de différents cancers sensibles aux rétinoïdes. Par 
exemple, la leucémie promyélocytaire aiguë est sensible au ttAR avec un taux de 
réponse de 90%. Un niveau anormal du ttAR peut permettre ou provoquer la 
dégénérescence épithéliale, comme la xérophtalmie et des troubles neurologiques 
comme dans la schizophrénie et les maladies, d ' Huntington, de Parkinson et 
d' Alzheimer. 
Une méthode sensible pour la quantification au niveau de trace du ttAR dans le milieu 
aqueux et un milieu de culture cellulaire supplémenté en sérum a été développée avec 
succès. La méthode consiste en un chromatographe liquide à haute performance 
(CLHP). La quantification a été effectuée sur une colonne de séparation Cl 8 avec 
élution isocratique dans un temps total d' élution de 25 minutes avec un ionisateur par 
l'électronébulisation (ESI) en mode négatif et couplée à un analyseur comprenant 
deux spectromètres de masse triple quadripolaire en tandem (SM/SM). Un mélange 
d'acétonitrile et de tampon d'acétate d'ammonium 0.1 M a été utilisé comme phase 
mobile pour faciliter la fonnation de paires d'ions au cours de l 'électronébulisation. 
Dans les conditions optimales, le ttAR génère un ion abondant correspondant à l'anion 
carboxylate [M-H] - de m/z 299 et un ion moins abondant correspondant à [M-C02] -
de m/z 255. La limite de détection de la méthode d'analyse est de 1 ng/mL à un 
rapport SIN de 3 pour le milieu aqueux analysé par CLHP-ESI-SM/SM et de 10 
ng/mL analysé par CLHP-UV. La méthode CLHP-ESI-SM/SM est 10 fois plus 
sensible que la méthode CLHP-UV. 
L'extraction liquide-liquide a été appliquée à la séparation, pré-concentration et 
détermination du ttAR pour des échantillons dans les milieux mentionnés. Les 
paramètres d'extraction ont été optimisés pour la récupération maximale ttAR. La 
limite d'extraction avec le facteur de pré-concentration de 2 est de 5 ng avec un taux 
de récupération de 34 % pour le milieu aqueux analysé par CLHP-ESI-SM/SM et la 
limite de l'extraction pour le milieu de culture cellulaire supplémenté en sérum est 
inconnue à cause de limitation du temps du projet. Un essai d'extraction effectué sur 
50 ng a donné un taux de récupération de 60% lorsqu'analysé par la méthode CLHP-
UV. La méthode pourrait être raffinée pour détecter les métabolites du ttRA. 
Mot clé : L'acid tout-trans rétinoïque (ttAR), analyse de trace, CLHP-ESI-SM/SM, 
CLHP-UV, milieu aqueux, milieu de culture cellulaire supplémenté en sérum aMEM: 
FBS (90: 10, v/v), extraction liquide-liquide. 
ABSTRACT 
All-trans retinoic acid (atRA) is an active metabolite of vitamin A which has 
important physiological functions . atRA controls cellular proliferation and 
differentiation, is essential in development and growth of organisms and acts on genes 
expression. atRA has several pharmacological and physiological properties useful in 
dermatology and in the treatment of several cancers that are sensitive to retinoids. For 
example, acute promyelocytic leukemia is particularly sensitive to atRA with response 
rate of 90%. Abnormal atRA levels may cause or permit epithelial degeneration such 
as in xerophthalmia and neurological disorders such as in Schizophrenia, Parkinson's, 
Huntington's and Alzheimer's diseases. 
A sensitive method was successfully developed for the quantification of atRA present 
at trace level in aqueous and serum supplemented cell culture media. The method uses 
an HPLC coupled to triple quadruple mass spectrometer using electrospray ionisation 
interface source (ESI) in negative mode. The separation was done on a C 18 column 
using an isocratic elution time of 25 min. A mixture of acetonitrile and aqueous 
ammonium acetate O.lM buffer was used as mobile phase, employed to facilitate ion 
pair formation in mobile phase during negative ion electrospray. atRA fonned an 
abundant ion [M-Hr of mlz=299 for the RA carboxylate anion and a less abundant ion 
for [M-Co2r m/z=255. Under optimal conditions, the instrumental detection limit of 
atRA were 1 ng/mL at SIN ratio of 3 for aqueous media analysed by HPLC-ESI-
MS/MS and 10 ng/mL when analysed by HPLC-UV. HPLC-ESI-MS/MS method was 
found to be 10 times more sensitive than HPLC-UV method for aqueous solution. 
Liquid-liquid extraction was applied for separation, pre-concentration and 
determination of atRA in aqueous and serum supplemented cell culture media. The 
extraction limit with a pre-concentration factor of 2 in aqueous media was 5 ng with a 
34% of recovery rate analysed by HPLC-ESI-MS/MS. As the result of time 
limitations, the extraction limit for serum-supplemented cell culture media aMEM: 
FBS (90: 10, v/v) was not determined. An extraction was performed at the quantity of 
50 ng with a recovery rate of 60% analysed by HPLC-UV. The method could be 
refined to detect atRA metabolites. 
Key words: all-trans Retinoic Acid (atRA) , Trace level analysis, HPLC-ESI-MS/MS, 
HPLC-UV, Aqueous media, Serum-supplemented cell culture media aMEM: FBS 
(90: 10, v/v), Liquid-Liquid extraction. 
INTRODUCTION 
Vitamin A is a fat-soluble vitamin and supports a wide range of biological actions 
(Chapman, 2012). Three forms of vitamin A and derivatives (Retinol , Retinal and 
Retinoic acid) are active in the body with their specific physiological roles (Tatum 
and Chow, 2005). Vitamin A doesn't have a direct physiological function in vivo but 
rather serves as precursor for the biologically active retinoids (Kane et al. , 2008). 
Retinoids are natural or synthetic derivatives of vitamin A (De Luka, 2003). 
Retinoids are important micronutrients in human diet and is taken up as retinol (Ruhl , 
2006). Retinol is a form of vitamin A that is found in animal food sources (Chapman, 
2012). Retinoids include vitamin A compounds such as retinol, retinal and retinoid 
derivatives and related molecules that bind to retinoid receptors which are 
subsequently responsible for specific biological response such as embryonic 
development, differentiation, proliferation and apotosis (Bushue and Yvonne, 2010 ; 
Van Breemen et al., 1998). Retinoic acid (RA) is produced when retinol is initially 
oxidized to retinal (RAL) by retinol dehydrogenase enzymes and then irreversibly 
converted to RA by retinal dehydrogenase enzymes (Gundersen, 2005). The most 
important biological activity occurs when retinol is transformed into RA by oxidation 
(McCaffery et al., 2002). RA is a ligand for nuclear retinoic acid receptors (RAR) 
and retinoic X receptors (RXR), which mediate its biological effects . An excess of, or 
a deficiency in RA can cause malformation during embryonic development 
(Gundersen, 2005 ; Sôderlund, Fex and Nilsson-Ehle 2005). RA can isomerize at 
several of its double bonds into various isomers. Among these, all-trans retinoic acid 
(atRA, tretinoin) and 9-cis-RA (alitretinoin) will bind and activate RAR and RXR. 
These receptors act as transcription factors controlling the multiplication of normal 
and cancerous cells. These two isomers are the most biologically active retinoids. In 
addition 13 -cis- RA (isotretinoin) is anti-inflammatory and act as an anti-tumour 
agent (Bushue and Yvonne, 2010). Three RA isomers (atRA, 13-cis-RA and 9-cis-
RA) are used clinically in dermatology and oncology (Cox, Muccio and Hamilton, 
2013). atRA and 9-cis-RA are only minor metabolites of retinol and beta-carotene. 
However, they show 1 OO to 1000 fold higher biological activity than either precursor. 
atRA binds to RAR while 9-cis-RA binds to both RAR and RXR (Roos et al., 
1998). Unfortunately, atRA is only present in very small quantity in human serum or 
plasma (Eckhoff and Nau, 1990). 
Pl9 stem cells are an embryonic carcinoma cells which can be easily cultivated, 
growing continuously in serum-supplemented media (McBumey, 1993 ). These cells 
are useful for the study of the early stages of neuronal differentiation in vitro . Stem 
cells have been found to provide an attractive alternative for the research and 
treatment of neurodegenerative diseases such as Parkinson's, Alzheimer's and 
Huntington's disease (Wu et al. , 2010). It was also shown that P19 stem cells provide 
a useful model for physiological study of RA activity (Solari et al. , 2010). For 
example, exposing P 19 cells to RA will promo te their aggregation and induces their 
differentiation in neuronal cells (Jones-Villeneuve et al. , 1983 ). 
Three important factors for method development are quantity level, resolution and 
media of analysis. In order to address these factors , the experiments were divided into 
two main groups related to the concentration and quantity range: 
• Micro molar concentration or pharmacological level. 
• Nano molar concentration or physiological level (Marill et al., 2003). 
The words high concentration related to pharmacological level and low concentration 
related to physiological level. 
The development of highly sensitive methods of atRA quantification (µg to ng) is 
required for the following reasons: 
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• RA isomerization occurs at very low concentrations. Furthermore, RA 
isomers have been shown to be active at nano molar concentration in vivo in 
many tissues (Van Merris et al., 2002). 
• Different doses of atRA act differently on cells (Bidad et al. , 2011 ). 
• At pharmacological concentration (µM) , which is relatively high for atRA, 
there is the decrease in the viability of immature dendrite cells (Bidad et al. , 
2011). 
• RA is only useful in specific concentration and an overdose of vitamin A is 
associated with toxicity (Van Breemen and Huang, 1996). 
• Pharmacokinetic delay to atRA was observed in oral administration of 
patients (Idres, Gerald and Flexor, 2001; Marill et al., 2003). 
• Cellular intake resistance was observed in presence of high concentrations 
(µM) of RA in vitro (Marill et al., 2003). 
• A rapid decrease of atRA concentration m plasma was observed m oral 
administration (Choi et al., 2003). 
• An increase in the concentration of the RA isomers causes a dramatic shift in 
the metabolic pathway of these retinoids (Van Merris et al. , 2002). 
• Biological effects on cell proliferation similar to those of atRA were observed 
at higher concentration in vitro for more polar and less active metabolites such 
as 4-oxo-RA and 13-cis-RA (Van Merris et al., 2002). 
Information on the physiologie concentrations of all-trans and 13-cis-RA is 
lacking for newboms and pregnant women (Soderlund, Fex and Nilsson-Ehle, 
2005). 
• RA is highly soluble oil which can diffuse into cell membranes (Kam et al. , 
2012). 
Quantification of RA relies heavily on resolution because the desired RA isomers 
have different polarities and, therefore, different affinities for RAR and RXR. This 
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causes them to act differently in vivo (Lan vers et al., 1996; McCaffery et al., 2002 ; 
Van Merris et al., 2002).It is beneficial to initiate study of atRA in vitro since it has 
recently been shown that atRA metabolites are active in vitro against human 
leukemia cells, inhibiting their growth and maturation (Idres et al., 2001 ). 
Among a series of isomers, atRA was chosen as an analyte of interest in method 
development because atRA has a relatively higher plasmatic concentration level 
compared to other retinoids and is responsible for most of the biological effects of 
vitamin A. It has a wide spectrum of biological activities such as cell growth, 
differentiation and morphogenesis. Furthermore, it is a precursor of several 
metabolites such as 4-0H-RA, 4-oxo-RA, 18-0H-RA and 5,6-epoxy-RA. atRA can 
also be isomerised to 9-cis-RA and 11-cis-RA. Therefore, the study of atRA has 
priority over the other isomers for the development of a sensitive and selective 
method for the trace analysis of atRA and its metabolites in physiological media. 
To meet this goal the following steps were planned: 
Extraction and trace analysis of atRA in aqueous media was optimized and then its 
concentration was quantified by HPLC-UV (high performance liquid chromatography 
with ultra violet detector) and HPLC-ESI-MS/MS (High Perfonnance Liquid 
Chromatography with Tandem Mass Spectroscopy Using Electrospray Ionization). 
Extraction and trace analysis of samples consisting of serum-supplemented cell 
culture aMEM: FBS 90: 10, v/v (Alpha Minimum Essential Medium: Fetal Bovine 
Serum) to which was added atRA and quantification by HPLC-UV and HPLC-ESI-
MS/MS. 
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CHAPTERI 
RETINOIC ACID CHEMISTRY 
1.1 History of Vi tamin A and the Retinoids 
Vitamin A was probably known by ancient Egyptians at least 3500 years ago. 
However, the modem investigation of the vitamin A began aroun~ 130 years ago 
(Wolf, 1996). 
• In 1816, François Magendie conducted nutritional experiments with dogs. 
• In 1880, Nicolai Lunin showed that there was a substance in milk that was 
essential for growth and Carl Socin discovered that the same substance, 
present in the yolk, was essential for chick growth. 
• In 1906, Frederick Gowland Hopkins suggested that there were unsuspected 
dietetic factors necessary for life. 
• In 1911 , Wilhelm Stepp demonstrated that the essential substance i'n milk was 
also fat soluble. 
• In 1913, Elmer McCollum and Marguerite Davis, Thomas Osborne and 
Lafayette Mendel showed that butter and egg yolk were superior ·to lard and 
olive oil in supporting the growth and survival of rats . 
• In 1918, the growth-supporting factor became known as fat-soluble vitamin 
A. 
• In 1932, Paul Karrer described the chemical structure of vitamin A. 
• In 193 7, Harry Holmes and Ruth Corbet isolated and crystallized vitamin A. 
• David Adrian van Dorp and Jozef were the first who applied the methods for 
the synthesis and characterization of vitamin A. 
• Research on the role of vitamin A in immunity and child survival continued 
into the 1990s (Wolf, 1996). 
Vitamin A Derivatives (The Retinoids) 
The retinoids are natural and synthetic derivatives of Vitamin A. They are divided 
into three categories (Chapman, 2012 ; Roos et al., 1998): 
• The non-aromatic retinoids such as ~-carotene, atRA and 13-cis-RA, the two 
latter are naturally occurring retinoids formed from the metabolism of retinol. 
They are present in small amounts in the body and were first synthesized in 
1955 . 
• Non-aromatic retinoids such as 9-cis-RA, the etetinate and the acitretin. 
• Polyaromatic retinoids (the arotinoids) such as adapalene, tazarotene, and 
bexarotene 
1.2 Structures, Nomenclature and Classification of the Retinoids . 
1.2.1 Structure 
Structurally, the retinoids consist of four isoprenoid units attached head to tail , with 
each unit having a (H2C=C(CH3)-CH=CH2) structure. The molecule can be 
considered to be divided into three parts, a trim ethylated cyclohexene ring, a 
conjugated tetraene side chain and a carbon-oxygen functionality (Barua and Furr, 
1998; Cox, Muccio and Hamilton, 2013 ; Luterotti, Sikovec and Bicanic, 2000). 
1.2.2 Nomenclature 
The numbering of the carbons of the main retinoid chain, according to IUP AC, is 
shown in Figure 1.1 (IUP AC, 1983). 
6 
16 19 20 
H3C CH3 CH3 , 
.. 
. 
. 
2 
8 10 12 
3 CH3 HO 4 18 
all-trans Retinoic Acid (atRA) 
Figure 1.1: atRA Chernical Structure (Cox, Muccio and Hamilton, 2013). 
1.2.3 Classification 
The retinoids can be classed by ongm, i.e. natural or synthesis. The naturally 
occurring retinoids include vitamin A and its physiological metabolites e.g. 
retinaldehyde, atRA and 9-cis-RA, all of which are provided to the human organism 
by the diet and their general chemical structure is shown in Figure 1.2. 
From 1967 onwards, synthetic retinoids were developed by changes in the nucleus 
and the side chain, as well as in the terminal group. Synthetic derivatives of vitarnin 
A are less toxic than the naturally-sourced vitamin and are used at present as 
therapeutics . The synt~esi s of retinoids has helped the advancement of the topical 
treatment forms of comedonal acne. Since 1968, more than 2000 molecules have 
been synthesized however, only a few are currently being used clinically. Among 
aromatic retinoids, etretinate was used clinically but now it has been replaced by 
acitretin. Adapalene was the first retinoid of a new class to be discovered. lt is used in 
the topical treatrnent of acne. The main structural features of synthetic retinoids are 
shown in Figure 1.2. 
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1.3 Isomerization and Degradation Products 
There are several reports on the formation of photoisomers of RA after exposing 
solution of the latter to light for short time (Urbach and Rando, 1994). As shown in 
Figure 1.1, each of double bonds in the conjugated polyene chain can undergo 
isomerization to give both mono cis and multiple cis isomers. However, due to steric 
hindrance, some of the isomers are not thermodynamically stable at room temperature 
and thus quickly isomerize to more stable forms . Mono cis isomers of retinoids play 
important biological roles. There are differences in receptor binding and thus, 
biological activity, for these isomers. Furthermore, some of isomers of RA are 
teratogenic. Therefore, determination of the exact isomerization products obtained 
from synthesis is essential (Ruhl, 2006). The chemical structures of these retinoid 
isomers are shown in Figure 1.2. 
Structure Products 
H3C CH3 CH3 CH3 
~ ~ ~ ~ Retinol OH 
CH3 
CH3 CH3 0 
~ ~ ~ ~ Retinaldehyde H 
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CH3 CH3 
~ ~ ~ 13-cis-RA ~ 
CH3 HO ~ 0 
CH3 
~ ~ 
9-cis-RA 
~ HO 0 
H3C CH3 H3C 0 
~ ~ ~ ~ 1 4-0H-RA OH 
CH3 
0 
H 
CH3 CH3 0 
~ ~ ~ ~ 4-oxo-RA OH 
0 
18-0H-RA 
OH 
OH 
H3C CH3 CH3 CH3 
~ ~ ~ 5,6-epoxy-RA 
CH3 HO 0 
CH3 CH3 CH3 OH 
~ ~ ~ ~ Acitretin 0 
0 CH3 
1 
CH3 CH3 
HO 
\ Adapalen 
/;c 
O-CH3 0 
Tazarotene 
1 
N 
1 
0 
Figure 1.2: Chemical Structures of Natural and Synthetic Retinoids and Derivatives. 
1.4 Source of Vitamin A 
Retinol and the carotenoids are the two main forms of vitamin A that exist in the 
human diet. Retinol is commonly found in animal foods like fish, meat and 
particularly in liver at high concentration. The carotenoids are organic hydrocarbons 
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composed of eight isoprene units, which act as pigments in plants, bacteria and algae. 
They are synthesized by photosynthetic microorganisms and plants. There are two 
types of carotenoids: 
• The xanthophylls (having oxygen). 
• The carotenes (not having oxygen). 
The carotene is plant-, not animal-sourced. Beta-carotene is probably the best known 
of these retinoids providing the red, orange and yellow pigments found in many fruit, 
vegetables and green leafy plants (Chapman, 2012 ; Luterotti, Sikovec and Bicanic, 
2000). 
1.5 Physiological Roles of Vitamin A 
1.5.1 Vision 
Night vision or dark adaptation is a physico-chemical phenomenon associated with 
vitamin A. The presence of a photosensitive pigment called rhodopsin in the rod cells 
of the retina, allows for this phenomenon. Rhodopsin, a derivative of vitamin A, is 
synthesized from 11-cis- retinal with a protein opsin. When rhodopsin is exposed to 
light of low intensity, 11-cis-retinal is isomerized to trans-retinal (Perlman, 
Tamarhaim and Schramek, 1983 ; Sieving et al. , 2001 ). 
1.5.2 Embryonic Development 
atRA is the major retinoid needed for the early stages of embryonic development. It 
regulates the formation of the germ layers and body axis and is involved in 
neurogenesis. It is important for the development the pancreas, Jung and eye organs 
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and is a critical element for vision (De Luca, 1991 ; Kam et al., 2012 ; Sharon et al., 
2000). It can also induce carcinogenesis if present in unadequate concentrations. 
1.5.3 Cellular Differentiation 
RA and its isomers influence many physiological processes and act as honnones to 
regulate gene expression. RA is the most potent factor for cell differentiation. atRA's 
ability to differentiate cells is the main focus of research into the development of 
therapies for prevention and treatment of various human cancers (Idres et al., 2001) 
1.5.4 Reproduction 
atRA supports both male and female reproduction and is also essential for the 
maintenance of male genital tracts and for spermatogenesis. Vitamin A is involved in 
the development of spermatozoa, avaries and placenta in addition to the growth of the 
embryo and in the differentiation and proliferation of epithelium cells. Low serum 
vitamin A in the mother is associated with infant morbidity or, indeed mortality 
(Clagett-Dame and Knutson, 2011). 
1.5.5 Immune System 
Vitamin A, used as dietary supplement, is believed to enhance resistance to infection. 
It is known as an anti-infection vitamin because it is essential for the proper 
functioning of the immune system. It plays an important role in the development and 
differentiation of white blood cells and the activation of T-lymphocytes via the 
binding of atRA to the RAR (Bidad et al., 2011). 
12 
1.5.6 Oncology 
The role of vitamin A (through RA) in cell differentiation, growth and control makes 
it very important in oncology. Many retinoids have been used alone or in combination 
for the treatment of several cancers such as basal cell carcinomas, squamous cell 
carcinoma of the skin, melanoma, cell lymphoma, acute promyelocytic leukemia 
(APL) , ovarian, lung, breast, prostate, mouth and renal cell carcinomas and squamous 
cell head and neck syndrome. Vitamin A and its esters are capable of inhibiting 
. . 
carcmogenes1s. 
1.5.7 Dennatology 
The importance of retinoids in dermatology was discovered by Wallach and Howe in 
1925 (Roos et al., 1998). This research group identified the epidermal changes which 
occur m abnormal keratinization in vitamin A-deficient animals . Vitamin A is 
presently a molecule of interest in dermatology because its effect on the 
differentiation and proliferation of epithelium cells. The mechanisms for action of 
retinoids on skin are still the subject of research. Nonetheless, it is known, from the 
study of epithelial morphogenesis rebuilding at a low dose atRA allows for the 
optimal formation of the epidermis. As the active precursor in the skin, atRA is 
converted in the epidermis and probably in the dermis into 13-cis-RA, 9-cis-RA and 
4-0H-RA. 
1.6 Metabolic Pathway of atRA 
The metabolism of atRA is complex and currently is only partially understood, the 
metabolism has different mechanisms depending on whether it is analysed in vivo or 
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in vitro. A few enzymes are known to participate in RA metabolism. The latter may 
play a role in cancer cell response or resistance to retinoid therapy (Marill et al., 
2003). atRA can be oxidized by P450 cytochrome to different metabolites and these 
metabolites may be further metabolised to water soluble glucuronides (Idres et al., 
2001). The metabolism of atRA occur in two phases: 
• First Phase in vivo 
atRA can be metabolized by isomerase into several isomers which can undergo phase 
1 metabolism into oxidized metabolites : 4-oxo-RA, 4-0H-RA, 18-0H-RA and 5,6-
epoxy-RA while these isomers are believed to be less biologically active and more 
polar than atRA. 
• Second Phase 
The second phase of retinoids metabolism involved the production of conjugated 
metabolites of atRA. The oxidized metabolites produced in phase 1 can undergo 
glucuronidation in animais and humans. Thus, at-retinol P-glucuronide, 13-cis-retinol 
p-glucuronide, at-4-oxo-retinol p-glucuronide, 13-cis-4-oxo-retinol p-glucuronide are 
all conjugated metabolic products. RA metabolism reduces biopotency and results 
into an auto-regulatory loop. Several groups have observed that atRA metabolites can 
stop the differentiation and growth of several cancer cell lines. The analysis of 
glucuronides products has shown that atRA-4-oxo-RA and 5-6 epoxy-RA are 
carboxyl-linked glucuronides whereas 4-0H-RA was glucuronidated via the hydroxyl 
group (Marill et al., 2003). Another interesting observation is that RA glucuronide 
shows activity in vitro and but not in vivo. The glucuronide derivatives doesn't bind 
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to RAR due to their polar nature which facilitates their excretion (Marill et al. , 2003). 
Thus the glucuronides are less interesting for use in cell differentiation studies. 
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CHAPTER II 
METHODOLOGY 
The choice of the method for atRA trace quantification was based on several 
considerations, i.e. desired level of concentration, the resolution and the nature and 
effect of the sample matrix. Furthermore, the speed and cost of analysis must be 
optimized. 
2.1 Reported Methods for RA Analysis 
Analytical methods for retinoids have been developed usmg vanous high 
perfonnance liquid chromatography-diode array detection (HPLC-DAD) (Van Merris 
et al. , 2002). HPLC coupled to thermal lens detection (Luterotti, Sikovec and 
Bicanic, 2000), HPLC coupled with ultra violet detector (HPLC-UV) (De Leenheer, 
Lambert and Glaeys, 1982 ; Gundersen and Blomhoff, 2001 Klvanova and Brtko, 
2002; Schmidt, Brouwer and Nau, 2003 ; Tatum and Chow, 2005), HPLC coupled to 
particle beam mass spectrometry (Lehman and Franz, 1995), electroionisation mass 
spectroscopy (Bempong, Honigberg and Meltzer, 1995), HPLC coupled with 
atmospheric pressure chemical ionisation tandem mass spectrometry (HPLC-APCI-
MS/MS) (Gundeson, Bastani and Blomhoff, 2007 ; Kane et al. , 2008 ; Wang et al., 
2001) and HPLC-ESI-MS/MS in both positive and negative modes (Lin, Jing and 
Jianping, 2011 ; Van Breemen and Huang, 1996) have also been reported. 
2.2 Categorisation for RAs 
Two different methods, routine and high sensitivity, were developed based on the 
required resolution, their applicability to research and the quantity to be analysed. 
};;;>- The routine method involves high performance liquid chromatography 
coupled with ultra violet detector (HPLC-UV), as is generally required for 
pharmacological level (µg) scale analyses (Marill et al., 2003). 
};;;>- The high sensitivity method of high performance liquid chromatography 
coupled with electrospray ionization mass spectrometer (HPLC-ESI-MS/MS) 
is more appropriate for ng scale quantification. This method is suitable for 
researchers who work in the field of embryonic development (Marill et al., 
2003) and may be applied to the physiological level quantification. 
2.2.1 HPLC-UV 
High perfonnance liquid chromatography coupled with a UV detector (HPLC-UV) is 
a powerful method for the analysis of atRA. The main advantages of HPLC-UV 
method are: 
};;;>- Rapid, low cost, accurate, accessible and suitable for routine analysis (Barna, 
2001). 
};;;>- atRA has a specific UV absorption. Retinoids absorb light in the high UV 
(Àmax= 325 to 370 nm) as the result of their conjugated polyene chains (Van 
Merris et al., 2002). 
};;;>- UV detection allows the possibility of simultaneous quantitative and 
qualitative testing (Van Merris et al., 2002). 
};;;>- No interfering peaks with similar retention tünes were observed in 
chromatogram of extracted atRA in both aqueous solution and serum-
supplemented cell culture media. 
};;;>- This method is not selective nor can one detect low or trace level 
concentrations with it. 
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2.2.2 High Sensivity Method (HPLC-ESI-MS/MS) 
High performance liquid chromatography electrospray ionization coupled with 
tandem mass spectrometry (HPLC-ESI-MS/MS) is a flow analysis technique for 
rapid and high through-put analysis (Ho et al., 2003 ). This method is one of the most 
powerful tools in modem analytical chemistry. It is particularly useful in trace 
analysis. HPLC-ESI-MS/MS is very powerful tool capable of analysing both small 
and large molecules of varying polarity, e.g. in complex biological mixtures 
(Banerjee and Mazumdar, 2012). 
ESI-MS has also become an important technique in clinical laboratories (Ho et al., 
2003). Most HPLC-ESI-MS/MS analyses are carried out using reverse phase liquid 
chromatography with a non-polar Cl 8 silica bonded stationary phase. The molecule 
of interest must be able to undergo charge changes via protonation and deprotonation. 
The main advantages of this method are: 
~ It is capable of providing both qualitative (structure) and quantitative 
(molecular mass or concentration) results for analytes (Ho et al. , 2003). 
~ It is a valuable method for complicated matrix analysis (Wu et al., 2004). 
~ lt is the most sensitive analytical method for structural characterization of a 
molecule (Banerjee and Mazumdar, 2012). 
~ lt is the most powerful method for target compound characterization. 
~ It allows for the possibility of obtaining the entire molecular mass by selecting 
the appropriate parent ion peak. 
~ Finally, it is a time saving method when a large number of samples must be 
analysed. 
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Limitations of HPLC-ESI-MS/MS are: 
);:> The selectivity and sensitivity of HPLC-ESI-MS/MS analysis not only 
depends on the ionization technique and mass spectrometer used, but also on 
the chromatographie technique chosen (Kostiainen and Kauppila, 2009). 
);:> The optimization of chromatographie and mass spectrometric conditions is 
required while maintaining a balance between sensitivity and resolution (Kane 
et al., 2005). 
);:> The mobile phase composition for the HPLC must be compatible with 
electrospray mass spectrometry. For example, nonvolatile ion pair reagents 
and/or buffers must be excluded to prevent precipitation in the ion source 
(Van Breemen and Huang, 1996). 
);:> Ionization suppression can occur when mass spectrometric analysis is carried 
out at atmospheric pressure (Manuur et al. , 201 l). 
);:> The signal response depends on many parameters: sample concentration, 
sample matrix, analyte characteristics, buffer, organic solvent and/or curtain 
gas purities as well as collision cell parameters and eluent composition. 
);:> There is no possibility to apply non-volatile additives and/or buffers in mobile 
phase as this can causes excessive background noise and/or rapid 
contamination of the interface source (Kostiainen and Kauppila, 2009). 
A summary of the numerous advantages using a high sensitivity method for analysis 
of atRA are as follows: 
);:> There is a favorable ionization efficiency due to conjugation and the 
carboxylic acid group in atRA (Hung, 1996). 
);:> Greater sensitivity allows for greater signal intensity and lower background 
noise (Hung, 1996). 
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~ Creating RA derivatives is not required for this method in comparison with 
other methods like Negative Ion Electron Capture Chemical Ionization (Hung, 
1996). 
~ This method has higher selectivity and does not require prolonged sample 
preparation in comparison of GC-MS (Peng et al. , 2014). 
2.3 High Sensitivity Instrumentation (HPLC-ESI-MS/MS) 
The figure 2.1 represents three components of a m~ss spectrometer : 
1. An ion source for producing gaseous ions from the sample m ionization 
compartment. 
2. An analyser for resolving the ions into their characteristics mass components 
according to their mass to charge ratio . 
3. An ion detector system which measures the relative abundance of each of the 
resolved ionic species and converts the ions into electrical signais. 
A sample introduction system is necessary to introduce the samples into the ion 
source such as in an HPLC. All mass spectrometers operate under vacuum allowing 
ions to reach the detector without colliding with the other gaseous molecules or atoms 
(Kang, 2008). 
,---------------------, 
1 GasP~!>? Ion; Ion 'S-Orting loci Detectlon 1 
Source 
1 
1 
1 
1 
Sampi~ 1 Vacuum Pu mps : Introduction " ____________________ _, 
M.3ss Spectru m 
Data ~ 
Data Output 
Figure 2.1: Components of a Mass Spectrometer (www.premierbiosoft.com). 
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2.3.1 Ion Source and Ionization Technique 
Electrospray Ionization (ESI) is conducted at atmospheric pressure ionization 
technique, and it is used to produce polar and ionic species in gas-phase ions at high 
voltage (Tang, Bruce and Hill, 2006). John Fenn, the first person to develop this 
method, shared the 2002 Nobel Prize in chemistry for the crafting ESI-MS. 
ESI promotes electrostatic dispersion and creation of aerosols and is sometimes 
improperly called electro-hydrodynamic atomization (Kebarle and Verberk, 2010). 
This ionization technique has totally replaced other earlier ones such as continuous 
Fast Atom Bombardment (F AB), Thermospray and Particle Beam Ionization (PBI) 
(Kostiainen and Kauppila, 2009). 
Mechanism of Action 
All stages of the ESI occur in atmospheric pressure regions of the machine and the 
sample proceeds through three major steps in the conversion from electrolytes in 
solution to gas phase ions (Figure 2.2) : 
1- Initial production of charged droplets in very small diameter ESI capillary tips . 
2- Shrinkage of the charged droplets due to sol vent evaporation. 
3- Gaseous ion formation. 
A voltage of 2-5 kV is applied across the capillary spray tip, and a high electric field 
at the capillary tip causes polarization of the solvent. The solution supplied to the 
capillary must be polar and one in which the analyte is soluble: (ex: MeOH or 
MeOH/H20; and ACN or ACN/H20). 
In the presence of an electrolyte, the solution must be sufficiently conducting and the 
positive and negative ions in solution sufficiently labile under the influence of the 
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field. A common electrolyte used in these solutions is ammonium acetate which 
provides an excess, at the surface, of NH/ as the positive ion. 
The droplets initially produced are expected to be approximately of similar size and 
positively charged due to an excess of positive electrolyte ions at the surface of the 
cane and the cane jet. The mode of charging, which depends on the positive and 
negative ions traveling in opposite directions under the influence of the electric field, 
has been called the electrophoretic mechanism. The droplets migrate downfield 
towards the oppositely charged electrode. Solvent evaporation at constant charge 
causes droplet shrinkage and an increase in the repulsion between the charges. 
Increasing repulsion overcomes the surface tension of the drop let and thus columbic 
fission can occur. Formation of a cane jet splits the charged droplet into numbers of 
smaller ones while further evaporation of the parent drop let leads to repeated fissions 
and generation of smaller drop lets. 
In 1882, Lord Rayleigh theoretically estimated the maximum amount of charge a 
droplet can carry which is called the Rayleigh limit. Evaporation of droplet 's solvent 
increases the charge on the analyte until Rayleigh limit is achieved. At this point, the 
droplet breaks apart and the analyte is accelerated toward the counter electrode and 
subsequently into mass spectrometer. 
+ 
- + + 
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Figure 2.2 : Mechanism of Electrospray Ionization (Ho et al., 2003). 
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Sensitivity is an important aspect of ESI-MS/MS, and depends on several factors 
including: 
);>- Ionization efficiency, defined as the method' s effectiveness in producing 
gaseous 10ns. 
);>- Ion transmission efficiency, defined as the fraction of electrospray current 
which enters the mass spectrometer and the ability to transfer the charged ions 
from an area of atmospheric pressure to the vacuum of the mass spectrometer. 
Limitations in ionization and transmission efficiencies lead directly to a reduction in 
the ESI-MS sensitivity (Page et al. , 2007). Severa! factors affect the ionization 
efficiency: 
);>- Interface design. 
);>- Flow rate. A lower flow rate provides better ionization efficiencies because it 
generates smaller initial droplets that require less solvent evaporation which 
offers a better sensitivity (Page et al., 2007 ; Tang, Bruce and Hill, 2006). 
);>- The chemical and physical properties of the analyte (pKa, hydrophobicity, 
surface activity, ion solvation, and proton affinity). 
);>- Eluent composition and volatilities, surface tensions, viscosities, 
conductivities, ionic strengths, dielectric constants, electrolyte concentrations, 
pH and potential gas-phase ion-molecule reactions (Kostiainen and Kauppila, 
2009). 
);>- Solvent charge separation (cation vs anion) . The conductivity of the solvent 
must be sufficient to achieve good sensitivity along with good stability. 
);>- Polarity of solvent. A more polar solvent better stabilizes multiply charged 
ions in solution. 
);>- Sensitivity is improved when higher proportions of organic sol vents are used. 
The signal response in ESI increases with increased amount of organic sol vent 
used (Kostiainen and Kauppila, 2009). 
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~ Smaller initial droplet s1ze mcreases the amount of charge per analyte 
molecule and improves the ionisation efficiency as well as the surface 
activity. 
~ Instrumental conditions and ion source voltages. 
ESI has numerous benefits: 
~ lt is an excellent method for the detection of analytes generated by HPLC. 
Furthermore, ESI coupling with an HPLC is relatively easy (Page et al. , 
2007). 
~ lt is a soft ionization technique which can produce the gas phase ions of large, 
thermally liable supermolecules (Banerjee and Mazumdar, 2012). 
~ ESI is sensitive, robust and reliable tool for the study of femtomole quantities 
of analytes in microliter volumes (Ho et al., 2003). 
~ Using ESI increases the speed of analysis for a variety of analytes of differing 
polarities such as organic or inorganic species, polymers, nucleic acids or, 
indeed, very high mass proteins in physiological matrices (Ho et al. , 2003 
Kebarle and Verberk, 2010). 
~ ESI allows for creation of intact multiply charged gas-phase biomolecules 
(Page et al., 2007), protonated and deprotonated molecular ions from 
compounds with high molecular weights (130 KDa) · as well as from 
thermostable compounds. 
~ ESI is particularly effective for analytes with a polar functionality (Banerjee 
and Mazumdar, 2012), like atRA which has an acidic carboxylic moiety. 
~ ESI is less affected by salt contaminations of the analyte solution than the 
other ionization techniques. 
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ESI Ionization Mode (Negative) 
Negative ion mode was seldom used in the past due to irreproducibility arising from 
several factors: 
~ It is more difficult to obtain a stable signal in negative vs positive mode 
because the electrical discharge occurs at lower electric field (Kostiainen and 
Kauppila, 2009). 
~ In negative ion mode mass spectroscopy, the ion sources are operated at 
pressure of up to 133Pa, producing a high concentration of low energy 
electrons which may directly react with sample molecules to fonn negative 
molecular daughter ions. 
~ Mass spectra in negative mode generally exhibit less fragmentation than in 
positive mode. 
~ The sensitivity of electron attachment process is very high for electronegative 
elements, and precursors which react as Bronsted based frequently give [M-
l r ions, which commonly undergo electron capture or anion attachment 
(Pavani et al. , 2012). 
Nonetheless reagent gases may be used to generate negative ions and acids, phenols 
and nitro compounds which are easily ionized in negative mode by ESI (Kebarle and 
Verberk, 2010). 
Mass spectra resulting from production of negative ions via ESI are more efficient, 
sensitive and selective than mass spectra produced in positive mode. Furthermore, the 
presence of acetic acid improves the signal response for ESI in negative mode (Wu et 
al. , 2004). In the current context, atRA has a medium polarity, having a non-polar 
hydrocarbon chain and a polar acidic group which can be ionized via negative mode 
ESI. 
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Figure 2.3: Diagram ofNegative Electrospray Ionization (Pavani et al., 2012). 
2.3.2 Mass Spectrometer 
Quadrupole mass spectrometers sort ions according of their mass-to-charge ratio 
(Miller and Denton, 1986). They consist of four circular sections arranged with their 
axes in a square array. The quadrupoles have a tuneable and a variable band pass 
region. At present, the most widely used tandem mass spectrometer is the quadrupole 
mass spectrometers. Only the first and third quadrupole scan and analyse the ions. 
The performance of the mass analyser is defined by such characteristics as accuracy, 
resolution of the mass range as well as the scan speed. Selected Ion Monitoring (SIM) 
is the most selective mode used for single quadrupole MS, while triple quadrupole is 
used for enhanced sensitivity and selectivity in multiple reaction monitoring (MRM) . 
Tandem mass spectrometry, having two stages of mass analysis, includes a product 
and a constant natural loss scan. 
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Figure 2.4: Schematic Diagram of a Triple Quadrupole Mass Spectrometer (Edmond 
de Hoffmann, 1996). 
Significant Advantages of the Quadrupole 
~ The shorter distance between the ion source and the detector having a 
relatively low pressure (S x10-5 Torr), allows for the coupling of a HPLC to 
the mass spectrometer (Miller and Denton, 1986). 
~ Quadrupole MS resolves ions on the basis of mlz instead of kinetic energy 
momentum (Miller and Denton, 1986). 
~ The quadrupole is relatively low cost while having bulk weight due to its 
mechanical simplicity. lt also avoids the slow scan speeds associated with 
magnets (Miller and Denton, 1986). 
Advantages of the Triple Quadrupole 
~ Triple quadrupole MS/MS offers higher selectivity due to double mass 
filtering (Schreiber, 2010). 
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);>- This allows for quantification of many targeted analytes m a single 
experiment. 
);>- Higher selectivities result in less interference from co-eluting compounds and 
the matrix (Schreiber, 2010). 
);>- The quadrupole collision chamber and the mass analyser allow for high 
efficiency fragmentations . 
);>- The triple quadrupole MS/MS is capable of analysing up to m/z 4000 with a 
precision of mlz O. l -0.2. 
);>- The triple quadrupole allows for better accuracy and reproducibility especially 
at low concentrations. 
);>- This technique has a better signal to noise ratio (SIN) allowing for a lower 
limit of quantification (Schreiber, 2010). 
);>- Speed of such scans are up to 5000 m/z per second. 
);>- Triple quadrupole MS/MS tolerates relatively lower pressures. 
2.4 Buffer Choice 
2.4.1 Strategies for Choosing the Right Buffer 
Small changes in the mobile phase pH have a dramatic effect on atRA analysis 
(Kaushal and Srivatara, 2010). Therefore, a buffer is used to maintain the pH of the 
solution for analysis within a narrow range. The nature of the buffer is detennined by 
its buffer capacity, i.e. , its resistance to change in pH when strong acids or bases are 
added. The doser the pKa of the buffer is to the desired pH, the greater is its buffer 
capacity and the better it controls the pH of the analysis, an important factor for the 
results (www.bartek.on.ca) ; one of the analyte should have a pH of 1.5 units above 
or below that of the mobile phase. A lower pH decreases the solubility of RA in 
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water and thus its analysis reqmres a mobile phase with a higher proportion of 
organic solvent for elution under reverse phase conditions . The buffer, therefore, 
must be chosen based on ability to maintain analyte ionization at the MS interface. 
An ammonium acetate-acetic acid buffer was used in the present study. Acetic acid is 
a monoprotic acid. 
Samples containing ionizable compounds are influenced by the pH of the mobi le 
phase. atRA is ionizable and strongly influenced by the pH of the mobile phase 
(Heyman and Henry, www.westermanalytical.com). 
HPLC separation and ESI-MS detection depend upon the buffer and other additive 
species. Depending on the analytical method used, two types of buffers were 
employed as shown in Table 2.1. 
Table 2.1: List ofBuffers Used for atRA Method Development. 
Buffer Ion Type Effective pH Tested Method 
pH Range 
Sodium Acetate CH3Coo- Non 4.8 5.2 HPLC-UV 
O.OlM Volatile HPLC-FLU 
Ammonium CH3COO- Volatile 4.3-5 .3 5.2 HPLC-UV 
Acetate 0.01 M and HPLC-MS/MS 
O.lM 
2.4.2 Advantages of the Presence of a Volatile Buffer in the Mobile Phase 
);:> This method employed an acidic, buffered mobile phase, which offers a rapid 
separation and detection of RA at the most sensitive wavelength (Tatum and 
Chow, 2005). 
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~ Ammonium acetate is a volatile buffer which doesn't precipitate in the ion 
source of an MS (Stering et al., 2010). 
~ Addition of ammonium acetate can improve signal stability and 
reproducibility (Kostiainen and Kauppila, 2009; Stering et al., 2010). 
~ Ammonium acetate removes other non-volatile salts and/or detergents via a 
buffer ion exchange in the cell culture medium (Stering et al., 2010). 
~ Ammonium acetate is an effective buffer for obtaining ESI signais for 
complex media that require a high concentration of essential salts (Stering et 
al., 2010). 
~ High concentrations of a volatile buffer can reduce the adverse effects of 
contamination in ESI (Stering et al., 2010). 
~ Ammonium acetate is highly soluble in an aqueous-organic eluent at pH 5 
(Schelinger and Carr, 2004). 
2.5 Extraction Method 
Biological samples are extremely complex matrices which contain many components 
that can interfere with the analysis of the target. Such samples cannot normally be 
injected directly into the spectrometer without sample extraction. Liquid-Liquid 
Extraction (LLE) is the most common technique for separation of organic products 
from a biological matrix (Waters, 2008). LLE separates the analyte from other 
interferences by partitioning the sample between two immiscible phases. The ability 
of LLE to separate a mixture depends on the relative solubility of each compound in 
the two immiscible solvents. The objectives of extraction of atRA from a 
physiological matrix are as follows: 
~ Isolate atRA and related metabolites from any interfering compounds. 
~ Dissolve atRA and pre-concentration in suitable solution. 
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~ Achieve high extraction efficiency and low handling loss. 
LLE Advantages and Limitations 
~ This technique is simple and low cost effective. 
~ In comparison to other direct methods, LLE is more time consuming. 
~ LLE requires an evaporation step for removal of excess organic sol vent before 
analysis. 
~ The formation of an emulsion is possible when two immiscible phases are 
used in the extraction procedure. 
~ The extracted volume of atRA, after filtering, was about 1 OO µL and each 
injection consumed 20 µL of this. The number of injections was, thus, limited 
as was the study of the stability of the extracted solution. 
Ali extractions were performed according to the protocol of (Bérubé et al, 2005) 
using the following media: 
~ Acidic media since a change in the pH of the sol vent can considerably change 
the solubility of an acidic organic compound and, therefore, affect the amount 
of recovered. 
~ A mixture of 50:50 v/v polar and non-polar organic extraction solvents was 
used (EtOAc and acidified hexanes in volumetric proportions) since atRA 
contains a polar functional group ( carboxylic acid) and a non-polar si de 
chain. A polar molecule requires a more polar organic solvent (EtOAc) for a 
high yield extraction from aqueous solution. The LLE steps will be shown in 
Chapter 4 (Method Development) . 
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2.6 Challenges Encountered in Trace Analysis Method Development for atRA 
~ A reasonable run time with a balance of sensitivity and selectivity is required. 
~ Successful separation methods for less polar metabolites generally fail to 
separate more polar ones (Van Merris et al, 2002). Since the retinoids have a 
wide polarity range, separation of particular samples can be difficult. 
~ Sorne retinoids have a long retention times when isocratic elution is used 
(Tatum and Chow, 2005). 
~ The method suggested for the quantification of RA uses a gradient elution 
which requires additional time for column re-equilibration (Tatum and Chow, 
2005). 
~ The carboxylic acid functional group in RA shifts to its non-ionized fonn 
when the pH drops. A change in the concentration of ammonium acetate or 
the pH of the eluent influences retenti on times and thus it is very important to 
control the mobile phase pH (Eckhoff and Nau, 1990 ; Van Merris et al, 
2002). 
~ An adjustment of buffer solubility in the aqueous-organic eluent is required to 
prevent the loss of electrospray ionization efficiency. 
~ There is a wide variation in physical and chemical properties of atRA and its 
isomers. For example, the solubility varies from soluble to insoluble in polar 
aqueous solvents and vice versa in non-polar solvents like hexanes. 
~ An adjustment in pH is also required for the optimization of an RA liquid-
liquid extraction when water-immiscible solvents such as n-hexane and ethyl 
acetate are used. 
~ Since it has four double bonds, RA is able to undergo isomerization and 
oxidation in air when exposed to the UV light. Sample preparation, handling, 
extraction and analysis must be performed under yellow light. 
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In addition, the following elements have been considered: 
);> An efficient protocol, the maintenance and control of the instrumentation 
(HPLC-MS) requires an optimized condition for day-to-day routine analysis 
to prevent lack of sensitivity in quantification of RA. 
);> Chemical contamination of the ESI probe should be monitored to avoid loss 
of sensitivity. 
);> The presence of acidic and catalytic components must be monitored during 
sample analysis (Gundeson, Bastani and Blomhoff, 2007). 
);> The development of anammox bacteria in the presence of ammonium acetate 
should be avoided during method development. 
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CHAPTER III 
EXPERIMENTAL SECTION 
3 .1 Physico-Chemical Properties of atRA 
atRA is yellow powder with an orange cast having the molecular formula of 
C20H280 2, a molecular weight of 300.4 and a melting point of l 80-182°C. Acid or 
alkali impurities in the solvent can affect the spectroscopie parameters. The molar 
absorptivity of atRA in ethanol is 44300 at 351 nm and in methanol is 45000 at 350 
nm (Aldrich Sigma). 
3.2 Handling, Storage and Laboratory Precaution 
>- atRA should be kept frozen at below -20°C. 
>- atRA can be expected to be stable for at least one year when stored at -20°C 
in an unopened ampule (Barua and Furr, 1998). 
>- Ali experiments (extraction and instrumental analysis) were carried out in dim 
yellow light since the retinoid molecule does not absorb light in the yellow 
range of the spectrum, that is, 570 nm-585 nm (Ruhl , 2006). 
>- Installation of black curtains was used to cover doors and windows m 
laboratories while working with the retinoids. 
>- Since some retinoids are highly teratogenic and can cause skin irritations, it is 
recommended that gloves be wom while working with them (Barua and Furr, 
1998). 
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3.3 The Polarity and Solubility of Retinoids 
The polarity and therefore the solubility of the retinoids varies from very soluble to 
insoluble in polar solvents like water and vice versa in non-polar solvents like 
hexanes. The retinoids can dissolve in chlorinated hydrocarbons such as 
dichloromethane and chloroform, however, the latter is acidic and should be avoided 
because it produces free radicals. Furthermore, care should be taken with 
dichloromethane because retinoids isomerize in chlorinated solvents (Barna and Furr, 
1998). The solubility of individual retinoids in organic solvents depends on the 
terminal functional group of the side chain. atRA has a carboxylic acid function and, 
thus, is soluble in methanol and ethanol as well as in acetonitrile but its solubility in 
water is low. Spectrophotometric and radioactive techniques were used to measure 
the water solubility of RA under physiological conditions. Hydration decreases the 
molar extinction coefficient of RA and shifts its absorption bathochromically (Szuts 
and Harosi, 1991 ). 
The maximum absorption wavelength is observed from 337 nm to 350 nm for RA 
dissolved in 1 ml methanol containing 2 drops of 0.01 N NaOH. The maximum 
wavelength shifted to about 350 nm upon addition of the same mentioned volume and 
concentration of HCl to 1 mL of the above atRA solution. The presence of 
conjugated double bonds in retinoids renders the molecular structure unstable in the 
presence of an oxidant, a strong acid and/or in a solvent which contains dissolved 
oxygen or peroxides (Aldrich Sigma). 
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3 .4 Chemical Products and Sol vents 
);> Purified atRA was provided by an organic laboratory (Pr. Breau's Laboratory, 
UQAM, Canada). 
);> Commercial atRA, glacial acetic acid (99.99%) and hexanes (HPLC grade) 
were obtained from Sigma Aldrich (Toronto, Ontario, Canada). 
);> Sterilized mixtures of serum-supplemented cell culture media aMEM:FBS 
(90: 10, v/v) were prepared by Pr. Paquin's Laboratory, UQAM, Canada. 
);> Ammonium acetate (ACS grade, 97%) and sodium acetate was obtained from 
Anachemia (T9ronto, Ontario, Canada). 
);> Acetonitrile (HPLC grade) and hydrochloric acid (37%) were obtained from 
Caledon Laboratory (Toronto, Ontario, Canada). 
);> Ethyl acetate (ACS grade) and methanol (HPLC grade) were obtained from 
the EMD Laboratory (Toronto, Ontario, Canada). 
);> Water (Nanopure grade) was obtained by filtering distilled water using a 
Thermo Fisher water purification apparatus (Branstead model) (MA, USA). 
3 .5 Solution Preparation 
3.5.1 Stock, Mother and Standard Solutions 
The atRA was dissolved in MeOH, producing a stock solution of exactly 1000 
µg/mL and then the solution was stored at -20°C. A mother solution of 10.0 µg /mL 
in MeOH was produced by diluting the stock solution with MeOH. The standard 
solutions were prepared freshly on the day of use by dilution of the mother solution 
with the proper volume of the desorption solution to obtain a range of concentrations 
between 10 to 1 OO ppb 
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3.5.2 Buffer Preparation 
Two buffers were prepared: a sodium acetate solution (0.01 M) and an ammonium 
acetate one (0.1 M). Both had a pH 5.2 and the method was adapted from a standard 
analytical method. 
• Sodium Acetate O.OlM 
. The buffer solution for the HPLC-UV was sodium acetate (0.01 M, pH 5.2). O.OlM 
Acetic acid solution was prepared by diluting glacial acetic acid (0.57 mL, 17.4 M) 
with nanopure water to a final volume of lL. The sodium acetate solution (O.OlM), 
was prepared by dissolving of sodium acetate (0 .8203g, MW: 82 .03 g/mol) in water 
(Nanopure l L). The sodium acetate buffer solution (0.01 M, pH 5.2) was prepared by 
mixing acetic acid (267 mL, O.OlM) with sodium acetate solution (733 mL, O.OlM) 
• Ammonium Acetate O. lM 
A suitable buffer solution for the high sensitivity method was found to be ammonium 
acetate (0.1 M, pH 5.2). This buffer can also be used in a HPLC-UV. The acetic acid 
solution (O. lM) was prepared by diluting acetic acid (2.8 mL, 0.35 M) in nanopure 
water (10 mL). The ammonium acetate solution (0.1 M) was prepared by dissolving 
ammonium acetate (O. l 927g) in nanopure water (25 mL). The ammonium acetate 
buffer (pH 5.2, O.lM) was prepared by mixing acetic acid (5.3 mL, O.lM) with 
ammonium acetate (14.7 mL, O.lM). Ammonium acetate solution (pH 5.2, O.lM) was 
used in the mobile phase as well as the desorption solvent (pH 5.2, 0.15 M). 
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• Preparation of Acidified Hex an es 
The acidified hexanes was prepared by mixing glacial acetic acid (25 µL , 17.4 M) to 
hexanes (10 mL HPLC grade). 
3.6 Instrumentation 
UV detection was performed at w 
AUFS. Fluorescent detection was pe 
avelength 343 nm with a sensitivity of 0.2000 
rformed at an excitation wavelength of 340 nm 
ams were recorded by the physico software and emission at 470 nm. Chromatogr 
( Pr. Pichet, UQAM, Canada, 2003) via a data acquisition interface. Table 3 .1 shows 
the instruments used in this work. 
Table 3.1: List oflnstruments Used for atRA Method Development. 
Type Manufacturer Model 
HPLCPump Th enno Scientific Spectra P4000 
HPLC Pump Waters 590 
HPLCPump Waters 2695 
Mass Spectrometer Waters Micromass Quattro LC 
UV Dual Detector Waters 2487 
FLU Multi Detector Hitachi L-7480 
FLU Spectrometer Hitachi F2000 
Pump Syringe Harvard 
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CHAPTERIV 
METHOD DEVELOPMENT, CLASSIFICATION AND OPTIMIZA TION 
Method development is classified according to quantification of atRA at either the 
pharmacological level (µg) or the physiological level (ng) . The aim of this project is 
the quantification of atRA in physiological level (ng); however, before attempting to 
create a method at this level, some preliminary pharmacological level information 
must be obtained. Based on the quantity of atRA, the method development was 
divided into two stages, initial and final. As shown in Table 4.1, the initial step 
focused on the quantification of atRA at a high mobile phase flow rate (1.5 mL/min) 
in which atRA was analyzed and quantified by HPLC-UV and HPLC-FLU. In its 
final stage, the study focused on low mobile phase flow rates (0.2 mL/min) at which 
atRA was analyzed and quantified by HPLC-UV and HPLC-ESI-MS/MS. 
Table 4.1: Defined Concentrations and Quantities in Method Development. 
Method Concentration Extraction Category 
Development Range (µg/mL) Quantity (µg) 
Detection and 
Analytical Methods 
Initial 1-15 10.0-0.2 Pharmacological HPLC-UV 
Level HPLC-FLU 
Final 1.00- 0.002 0.200 - 0.005 Physiological HPLC-UV 
Level HPLC-ESI-MS/MS 
Note: Ranges are stated from lowest to highest 
4.1 Initial Method Development and Optimization (atRA Pharmacological Study) 
The detection methods used at the pharmacological level are HPLC-UV and HPLC-
FLU. These methods are less sensitive but more rapid. Nonetheless, they are useful 
for the following reasons: 
);> It allows for the selection of the better method: HPLC-UV vs HPLC-FLU, 
based on analytical parameters such as the limit of detection, the linearity 
range and the quantification domain and limit. 
);> It is possible to study atRA at high or low flow rates without any restrictions. 
);> It is possible to apply non-volatile or volatile buffer in the mobile phase for 
the study of their effect on extraction recovery rate. 
);> It is possible to study the effect of flow rate on the extraction recovery rate as 
well as the analytical parameters in different mobile phases (i.e. ACN vs 
MeOH). 
);> It allows for a study of the efficiency of an extraction protocol at high or low 
flow rates in aqueous and serum-supplemented cell culture media. 
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Pharmacological level quantification in early method development was aimed at: 
);> Collecting information about the physico-chemical properties of the analyte of 
interest (atRA) via a spectroscopie study. 
);> Determining the stabilities of the atRA mother and standard solutions. 
);> Determining the atRA's light sensitivity 
);> Comparing evaporation and calibration curves to evaluate the Joss of analyte 
via evaporation. 
);> Determining the efficiency of extraction and analysis at high flow rates in 
aqueous and serum-supplemented cell culture media. 
4.1.1 Ultra Violet (UV) and Fluorescent Spectroscopy Studies 
The UV spectroscopy study was performed with a UV visible spectrometer using 
atRA solution in MeOH (15µg/mL). As shown in Figure 4.1, the maximum 
absorbance was found at 343 nm. 
\,., 
\ 
Figure 4.1 : UV Absorbance Spectrum of atRA Recorded between 250 to 470 nm at a 
Concentration of 15 µg/mL in MeOH. 
The fluorescence spectroscopy of an atRA solution in MeOH (15µg/mL) was 
recorded over the range of 340-640 nm with a Hitachi fluorescent spectrometer 
F2000. Excitation was determined to be 343 nm. As demonstrated in Figure 4.2, 470 
nm appears to be the optimal emission wavelength for the detection of atRA. 
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Figure 4.2: Fluorescence Emission Spectrum of atRA at a Concentration of l 5µg/mL 
in MeOH Using 343nm at the excitations wavelength. 
UV and FLU spectroscopie characteristics of an atRA solution are summarized in 
Table 4.2. 
Table 4.2 :Spectroscopic Characteristics for a Solution of atRA in MeOH (15 µg 
/mL) 
UV À Optimal : 343 nm 
À Exc itation : 343 nm 
FLU Sean from 340 to 640 nm 
À optimal: 470 nm 
It should be mentioned that the results presented in the following sections are for the 
pharmacological level which was analyzed by HPLC-UV using a HPLC pump 
spectrometer P4000, mobile phase MeOH:NaOAc O.OlM (85:15 , v/v) at a flow rate 
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of 1.5 mL/min. A Waters 2487 UV detector and a Phenomenex Luna Cl 8(2) 
separation column, (5 µm, 150mm x 4.60 mm ID) were' also used. 
4.1.2 Evaluation of atRA Mother Solution Stability 
A mother solution (10 µg/mL) was prepared in MeOH from stock solution. It was 
monitored by HPLC-UV at intervals of 24 hours for sixteen days. As shown in Figure 
4.3, the results demonstrate that there was no significant change in the atRA signal 
intensity during this period. Therefore, a 16d interval was chosen for the preparation 
of fresh mother solution. 
11 000 
8500 • • • • 
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Figure 4.3: Stability Evaluation of atRA by HPLC-UV Analysis of a Mother 
Solution (10 µg/mL) Over 16 Days. 
4.1.3 atRA Light Sensitivity Study 
atRA is a light sensitive compound, therefore, appropriate storage and handling of the 
solution is very important. To study atRA photo-isomerization and the effect of light 
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on the rate of transformation; transparent and amber glass vials were chosen for this 
study, as indicated in Table 4.3 . This study was performed using the two types of 
vials, under different conditions, that is, 
~ Without or with an exposition to light for 25 min, 
~ The presence or absence of aluminums foil around the vials. 
Table 4.3: Type of Vial and Presence or Not of Light for Solution of atRA. (Entries 
1 to 6 are for Figures 4.4 and 4.5) 
Entry 
1 
2 
3 
4 
5 
6 
Vials Containing atRA Solution 
Transparent glass vial not wrapped with aluminum foi! 
Transparent glass vial not wrapped with aluminum foi! 
Arnber glass via! not wrapped with aluminum foil 
Amber glass via! not wrapped with aluminum foi! 
Amber glass vial wrapped with aluminum foi! 
Amber glass via! wrapped with aluminum foi! 
Light 
(25 min) 
Exposed 
Not Exposed 
Exposed 
Not Exposed 
Exposed 
Not Exposed 
The transformation rates were determined by variations in the signal intensities of the 
HPLC-UV chromatograms. Figure 4.4 shows the chromatograms for atRA in MeOH 
(1 Oµg/mL). The dotted trace resulted from the use of a transparent glass via! which 
was not wrapped by aluminum foil and exposed to light for 25 min (Entry 1) and the 
solid lined one resulted from use of amber glass vials wrapped with aluminum foil 
and unexposed to light for 25 min (Entry 6). Each chromatogram has two peaks, one 
representing atRA and the other representing 1somerization products. The 
transformation rate was calculated by dividing the measured area of the first peak 
(attributed to unknown isomerization products) by the area of the two peaks. 
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Figure 4.4: Comparison of HPLC-UV Chromatograms of atRA and Isomerization 
Products obtained from an Exposed (Table 4.3 Entry 1; dashed line) and Unexposed 
(Table 4.3 Entry 6; solid line), mother solution (10 µg/mL). 
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Figure 4.5: Comparison of atRA (Blue) vs Products Generated from Varied 
Exposures to Light (Red). 
These results demonstrate that atRA is a light sensitive. Therefore, it is recommended 
that amber glass vials wrapped with aluminum foil be used for handling and storage 
of stock and standard solutions. 
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4.1.4 Comparison between Evaporation and Calibration Curves for atRA 
In order to evaluate the loss of analyte during the evaporation process, the 
evaporation and calibration curves were compared. Figure 4.6 shows the change in 
peak area vs. the concentration of atRA. The slopes of calibration and evaporation 
curves were 7845 and 7503 , respectively, that is, they were quite close. This indicates 
that using a stream of nitrogen would not result in a significant loss of atRA. 
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Figure 4.6: Comparison of Evaporation and Calibration Curves for atRA 
4.1.5 atRA Pharmacological Level Extraction at Buffered Mobile Phase 
The extractions of atRA were performed in µg quantities (at a pharmacological level) 
in aqueous and serum-supplemented cell culture media. The effect of different 
extraction parameters on the recovery rate were determined. A HPLC-UV was used 
at a high flow rate (1.5 mL/min) with MeOH:NaOAc O.OlM (85:15 , v/v) as the 
mobile phase. 
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• atRA Extraction in Aqueous Media 
The extraction procedure followed was that of Bérubé et al. ,2005 with the following 
modifications: 
>- The mobile phase was MeOH:NaOAc 0.01 M (85: 15, v/v) and the desorption 
solvent was MeOH. 
>- The acidified hexanes was prepared by adding 2 drops of glacial acetic acid to 
hexanes (10 mL) via a Pasteur pipette. The resultant solution was mixed for 
15s. 
>- The volume of organic solvent (EtOAc: Acidified Hexanes, 50:50, v/v) used 
for the extraction was 5 mL. 
>- Volume of desorption solvent (V2) used varied from 0.2 to 5 mL. 
Extraction Protocol 
1- The atRA mother solution of 10 µg/mL in MeOH was freshly prepared by dilution 
of the stock solution (1000 µg/mL) on the day of analysis after having been warmed 
to room temperature. 
2- The aqueous solutions of atRA were prepared by dilution of the mother solution in 
water (C 1) and a volume (V 1, 1 to 5 mL) of this solution was transfered to glass a 
tube. 
3- The same volume of MeOH was then added to each tube. 
4- A solvent mixture (5 mL) composed of EtOAc:Acidified hexanes 50:50 v/v was 
added to each tube. 
5- The solution was mixed for 5 mm and left to rest until phases separated 
(approximately 1 min). 
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6- The upper organic phase was tranferred to a glass test tube and evaporated almost 
to dryness under nitrogen at room temperature. 
7- A second extraction was obtained in the same manner (i.e. steps 4 to 6). 
8- On the other hand, a third extraction was performed as before but with the use of 
acidified hexanes (5 mL) as the extracting solvent. 
9- The combined extracts was evaporated to dryness at room temperature under a 
gentle stream of nitrogen gas. 
11-The residue was dissolved in MeOH (V2,200 µL). 
12- A volume of 20 µL was injected into the HPLC. 
13- The peaks of atRA were identified by comparing with atRA dissolved in MeOH 
and not subjected to extraction. Blank extraction solution was injected prior of the 
extraction solution and the absence of atRA signal was verified. 
14- The extraction recovery rate was determined from the area ratio of the extraction 
solution vs a standard solution at the same concentration. 
The extraction protocol is shown in figure 4. 7 
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Injeccion 
HPLC-UV < 
Vortex ] 
Figure 4.7: Schematic of atRA Liquid- Liquid Extraction. 
~ Effect of atRA SampleVolume on Extraction Recovery Rate 
The effect of sample volume on extraction recovery rate from aqueous media was 
determined using a solution atRA (C 1, 10 µg/mL). Different volumes of the solution 
(1 to 5 mL) were used in the above extraction protocol. The results are shown in 
Table 4.4 and figure 4.8 which demonstrate that the recovery rate slightly decreases 
with an increase of sample volume. 
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Table 4.4: atRA Extraction Parameters for Samples Volumes and Extraction 
Recovery Rate. 
C1 V1 Quantity V2 C2 PCF a Recovery Rate 
(µg/mL) (mL) (µg) 
10 1 10 
10 2 20 
10 3 30 
10 5 50 
a: Pre-Concentration Factor 
80 
60 
cf 
~ 40 ~ 
è 
Q) 
6 20 
u 
Q) 
~ 
0 
0 
(mL) (µg/mL) 
0.2 50 5 
0.2 100 10 
0.2 150 15 
0.2 250 25 
2 3 4 
atRA Sample Volume, mL 
Figure 4.8: Effect of atRA Sample Volume on Extraction Recovery Rate. 
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~ Effect of atRA Sample Concentration on Extraction Recovery Rate 
5 
The effect of sample concentration on extraction recovery rate from aqueous media 
was determined using a fix atRA sample volume (V1) of lmL. Different 
concentrations of atRA from (C 1, 0.2 to 10 µg/mL) were used in the extraction and 
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the results are shown in Table 4.5 and Figure 4.9. The results demonstrate that the 
extraction recovery rate was optimal at 2 µg/mL. 
Table 4.5: atRA Extraction Parameters for the Study of Effect of Sample 
Concentration on Recovery Rate 
c, v, Quantity V2 C2 PCF Recovery Rate 
(µg/mL) (mL) (µg) (mL) (µg/mL) (%) 
0.2 1 0.2 0.2 1 5 51 
2 1 2 0.2 10 5 80 
10 1 10 0.2 50 5 62 
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Figure 4.9: Effect of atRA Sample Concentrations on Extraction Recovery Rate. 
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• atRA Extraction m Serum-Supplemented Cell Culture Media aMEM:FBS 
(90: 10, v/v). 
The extraction protocol was the same as that used for atRA in aqueous solution. The 
extraction of atRA using serum-supplemented cell culture media was performed and 
then repeated 3 times. The results show an average recovery rate of 73± 10% 
4.2 Final Step of Method Development (atRA Physiological Level) 
This development step was time-consuming because two of the major parameters 
required optimization. The decrease in the quantity of atRA from a pharmacological 
to a physiological amount requires a more sensitive method. Thus additional 
optimization was required for the transition from HPLC-UV to HPLC-ESI-MS/MS. 
Nevertheless, preliminary knowledge gathered from the HPLC-UV method was 
subsequently used for the development of the HPLC-ESI-MS/MS method. To this 
end, the following modifications were required: a reduction in the flow rate of the 
mobile phase from high to low (1.5 to 0.2 mL/min) and a modification of the buffer 
from non-volatile to volatile. Initially, HPLC-UV was used to determine these 
parameters while selecting a mobile phase. 
4.2 .1 Qualitative Assay Using HPLC-ESI-MS/MS 
Qualitative assays were investigated with the idea of developing a specific HPLC-
ESI-MS/MS method. Also, optimal conditions were needed to be found and a study 
of the effect of collision energies and gas on the formation of an intense specific ions 
(255 m/z) for atRA were pursued. For the development of the highly sensitive HPLC-
ESI-MS/MS method, qualitative assays were perfonned using a syringe pump fitted 
directly onto the MS section and the data acquisition was set in continuum mode. 
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Qualitative Assays with Buffered Mobile Phase MeOH:NH40Ae (0.01 M 85:15, v/v) 
~ Analysis in Sean Mode 
A solution of 10 µglmL of atRA dissolved in the mobile phase was injeeted and 
eluted with Me0H:NH40Ae O.OlM (85: 15, v/v) as mobile phase at flow rate of 0.1 
mL/min. Analysis in sean mode was performed using mass deteetion ranging from 
80-320 m/z . As shown in figure 4.10, two abundant ions were identified at (m/z 255) 
and (m/z 299) in the following mass speetra. 
100 150 200 250 300 
m/z 
Figure 4.10: Mass Speetrum in Continuous Sean Mode Observed for an atRA 
Solution of 10 µglmL Dissolved in MeOH:NH40Ac O.OlM (85:15, v/v). 
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The same assay, but with a lower concentration of atRA (1 OO ng/mL), was performed 
and is shown in Figure 4.11 . The result demonstrates that the two aforementioned 
peaks are present in trace amounts . 
3,0E+06 
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100 150 200 250 300 350 
m/z 
Figure 4.11 : Mass Spectrum in Continuous Sean Mode Obtained for an atRA 
Solution of 100 ng/mL Dissolved in MeOH:NH40Ac O.OlM (85: 15 v/v) . 
);> Analysis Using Tandem Mass Spectroscopy (MS/MS) 
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MS/MS analysis was performed in daughter ion mode with an atRA solution of 
1 OO ng/mL at the flow rate of 0.1 mL/min. The pressure of the collision gas and 
its energy were set at 17x10-3 mbar and at -29 eV, respectively. As shown in 
Figure 4.12, an important peak is obtained for atRA precursor ion of m/z 299 
corresponds to [M-Hr. Also observed was a less important peak at m/z 255, 
identified as [M-Co2r. The relative abundance of the m/z 255 ion peak to that of 
the precursor ion is about 3%. Like the other reported methods using MS, no 
major fragmentation of atRA was observed by ESI in negative mode with a 
buffered mobile phase (Van Breemen and Huang, 1996). 
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Figure 4.12: MS/MS Mass Spectra in Daughter Mode of an atRA Solution of 100 
ng/mL Dissolved in MeOH:NH40Ac O.OlM (85:15, v/v). 
~ Effect of Collision Energies on the Fragmentation of the Precursor Ion in 
Tandem Mass Spectrometry 
Tests were performed with different collision energies so as to optimize the system. 
The result demonstrates that changing the collision energy in the range between -29 
to -60 eV did not have a significant effect on the production of the specific ions mlz 
255 for this type of mobile phase. As shown in Table 4.6 and Figure 4.13, atRA does 
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not generate an intense daughter peak using this buffered mobile phase. A strong 
daughter ion peak is required for a high sensitivity analysis. 
Table 4.6: Signal Intensity of Daughter Ion/ Precursor Ions Ratio vs Collision 
Energies Using the Buffered Mobile Phase Me0H:NH40Ac O.OlM (85 : 15 , v/v). 
Collision Energy 
(eV) 
-29 
-40 
-50 
-62 
5,0E+04 
4,0E+04 
3,0E+04 
........ 
ro 
~ 
.~ 2,0E+04 VJ 
l ,OE+04 
O,OE+OO 
-29 
Precursor Ion Daughter Ion 
(m/z 299) x 103 (m/z 255)x 103 
49.0 1.4 
5.9 3.4 
8.4 4.5 
6.5 2.4 
-40 -50 
Collision Energy (eV) 
mlz (255/299) 
-62 
(%) 
3 
57 
54 
37 
m/z 299 
m/z 255 
Figure 4.13: Effect of Collision Energies on Signal Intensity of the Precursor (blue) 
and Daughter (red) Ions for atRA Solution of 1 OO ng/mL Dissolved in 
MeOH:NH40Ac 0.01 M (85:15, v/v). 
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• Qualitative Assay with Non-Buffered Mobile Phase MeOH:HOAc lmM 
(75:25, v/v) 
The signal intensity of specific daughter ion plays a key role in method development 
for the trace analysis of atRA. As shown in the previous section, the solvent MeOH: 
NH40Ac was not suitable for these analyses . Therefore, a non-buffered mobile phase 
was chosen, as shown in Figure 4.14. This mobile phase allowed for an increase in 
the ratio of daughter ion to precursor. 
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Figure 4.14: MS/MS Mass Spectra in Daughter Mode of an atRA solution of 1 OO 
ng/mL Dissolved in MeOH:HOAc lmM (75:25, v/v) . 
~ Effect of the Collision Gas (Argon) on Fragmentation of atRA Using Non-
Buffered Mobile Phase 
To study the effect of argon as a collision gas for the fragmentation of atR A, MS/MS 
analyses were performed in the presence and absence of argon. The results are shown 
in Figure 4.15 and Figure 4.16, respectively. The results demonstrate that there are no 
significant changes in the signal intensity of the m/z 255 ion in the presence or 
absence of argon. 
2,0E+06 [M-Hr l 
l,5E+06 
-~ l,OE+06 
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Figure 4.15: MS/MS Spectrum of an atRA Solution of 1000 ng/mL in the Presence 
of Argon (1.9 10-3 mbar) Dissolved in MeOH:HOAc lmM (75:25, v/v). 
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Figure 4.16: MS/MS Spectrum of an atRA Solution of 1000 ng/mL Dissolved in 
MeOH:HOAc lmM (75 :25, v/v) in the Absence of Argon. 
Another test was performed with an increased pressure of argon gas . The result 
demonstrates that this change did not affect the signal intensity. As shown in Figure 
4.17, an acidic non-buffered mobile phase generated abundant specific ions at m/z 
255 at very low concentration contrary to the buffered one MeOH:NH40H O.OlM 
(85: 15, v/v). Therefore, MS/MS analysis were done without argon. However, a 
filtering mode was used. Thus the first quadrupole mass filter was used for precursor 
ion selection (m/z 299) and the second, again in filtering mode, was used for 
increased detection and sensitivity allowing for a better limit of detection (LOD). 
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Figure 4.17: MS/MS Mass Spectra of an atRA Solution of 10 ng/mL Dissolved in 
MeOH:HOAc lmM (75:25, v/v). 
);;:- Parameters of ESI-MS/MS 
The optimized parameters of mass spectrometer including ESI interface, mass 
analyzer and aquisition data are summerarized in TabJe 4.7. 
Table 4.7: Parameters for Analysis of atRA by ESI-MS/MS . 
ESI 
Capillary -3 .20 kV 
Co ne -32 V 
Extractor 3V 
RF Lens 0.50V 
Source Block Temperature 140 °C 
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Desolvation Temperature 
Mass Spectrometer Parameters 
MS1 
Entrance 
Exit 
Ion Energy 
Ion Energy Ramp 
LM Resolution 
HM Resolution 
Ion Energy 
Ion Energy Ramp 
LM Resolution 
HM Resolution 
Multiplier 
Aquisition Parameters 
Start Mass 
Set Mass 
End Mass 
250 °C 
20 V 
O.OV 
0.4 V 
O.OV 
1.2 
1.2 
2.5 V 
O.OV 
O.OV 
5.6 V 
650 V 
297.2 
299.2 
301 .2 
MS Function Type Daughter of 299 
Acquisition Format Continuous 
Slope Gain 500 
Inter Sean Time (secs) 0.10 
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62 
Gas flow 
Desolvation Gas Flow 709 L/h 
Nebulization Gas Flow 75 L/h 
Pressure 
Analyser Vacurnm 5.29 e-6 mbar 
Gas Cell 3.7 e0 mbar 
4.2.2 Quantitative Assays Using HPLC-ESI-MS/MS 
• Assays with Non-Buffered Mobile Phase 
The information obtained from the qualitative study was used to perfonn the first 
quantitative analysis using ACN:H20 :HOAc (95 :4.8:0.2, v/v) with the extraction of 
atRA in aqueous media. The second assay was performed by increasing the aqueous 
portion of the mobile phase while decreasing the HOAc from 0.2 to 0.1 then to 0.01 
v/v. 
);> Analysis of atRA Extract by HPLC-ESI-MS/MS Using Non-Buffered Mobile 
Phase 
The extraction protocol was same as that described in above in the method 
development section. However, several parameters were modified and thus, the 
revised protocol is described here. 
1- Aqueous atRA solutions of various concentrations were prepared from the mother 
solution of 10 µg/mL in MeOH . A volume (0.4 mL) of each aqueous solution was 
transferred to a glass tube. 
2- HPLC grade MeOH (0.4 mL) was added to the glass tube containing the atRA 
solution. 
3- A sol vent mixture 1.3 mL of of EtOAc: Acidified Hexanes ( containing 0.90 % v/v 
of HCl 4N/ Hexane) 50:50 v/v was subsequently added to the tube. 
4- The mixture was stirred for 5 min at the speed of 5000 RPM. 
5- The organic phase was transferred to a test tube and evaporated almost to dryness . 
6- The extraction was performed two times and then another extraction was done 
using 1.3 mL acidified hexanes instead of 1.3 mL EtOAc:Acidified Hexanes 50:50 
v/v. 
7- The combined extractions was evaporated to dryness at room temprature under a 
gentle stream of nitrogen gas. 
8- The residue was dissolved in 200 µLof desorption solvent (MeOH). 
9- The final extracted solution was filtered on a 0.45 µm filter before injection. 
10- A volume of 20 µL of the resultant solution was injected into the reverse phase 
HPLC system. 
);;>- Effect of Presence of Acid in a Non-Buffered Mobile Phase on Extraction 
Recovery Rate 
To study effect of the acidity in a non-buffered mobile phase on extraction recovery 
rate, the extraction of a fixed quantity of atRA (80 ng) using the protocol described 
above in aqueous media. Figure 4.18 shows the chromatograms of extracted atRA 
solutions with different compositions of the mobile phase. The dashed line represents 
the chromatogram of the extracted atRA solution eluted with ACN:H20 :H0Ac 
(95:4.8:0.20, v/v) while the solid line represents the extract solution eluted ACN: 
H20:HOAc (95:4.99:0.01, v/v) . The latter was the best choice for non-buffered 
mobile phase since it offered a recovery rate of about 72%. The results also 
demonstrate that, in a non-buffered mobile phase, the proportion of acid leads to a 
63 
wide variation in results and irreproducibility in the extraction recovery rate. The 
results indicate that ACN:H20:HOAc (95:4.9:0.01 , v/v) was the best choice of the 
mobile phase since it offers the best signal intensity for both extraction and standard 
solutions in comparison to those obtained from more acidic ones. 
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Figure 4.18: Comparison of Extraction Recovery Rate for 80 ng of atRA with Non-
Buffered Mobi le Phase ACN:H20:HOAc (95 :4.8:0.2 v/v, dashed line) and 
ACN:H20:HOAc (95:4.99:0.01 v/v, solid line); HPLC Pump: Waters Model 2695, 
Separation Column Phenomenex Luna Cl8(2) (3 µm , 100 mm x 4.6 mm ID) and 
Flow Rate: 0.2 mL/min. 
).;;> Effect of Acid in Organic Extraction Solvents (Hexanes) on the Profile of the 
Extracted atRA spectra 
To study the effect presence of acid in the orgamc extraction solvents, three 
extractions of 80 ng of atRA were performed with a same volume of acidic organic 
solvents: EtOAc: Hex 50:50, v/v containing 0.30 %, 0.60 % and 0.90 % HCl (4N) : 
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Hex v/v. The resulting chromatograms of the extracted atRA are shown in Figure 
4.19. They display undesired double peaks eluting at around 18 min. These are 
present in all extraction profiles and will cause interference because they are very 
close to the retention time of atRA. These undesired peaks are also present in 
chromatogram of the blank extraction eluted with non-buffered mobile phase and 
thus are attributed to the acid (HCl, 4N) used for acidification of the hexanes. 
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Figure 4.19: Chromatograms of atRA Solutions Extracted with EtOAc: Hex, 50:50, 
v/v Containing Different Amounts of HCl (4N). HPLC Pump: Waters, Mobile Phase: 
ACN:H20 :H0Ac (95:4.99:0.01 , v/v), Separation Column: Phenomenex Luna Cl 8(2) 
(3 µm , 1 OO mm x 4.6 mm ID) and Flow Rate: 0.2 mL/min. 
~ Results Obtained from Analysis by HPLC-UV and HPLC-ESI-MS/MS 
Each atRA extraction was repeated three (3) times (triplicate) . The parameters used 
and the analysis of the extracts by HPLC-UV and HPLC-ESI-MS/MS are given in 
Tables 4.8 and 4.9, respectively. 
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Table 4.8: atRA Extraction Parameters for Analysis by HPLC-UV Using 
ACN:H20 :HOAc (95:4.99:0.01 , v/v) . 
C1 
(ng/mL) 
100 
200 
300 
80 ! 
~ 60 
Q)~ 
~ 
i:x:: 40 
è 
Q) 
> 
8 20 Q) 
~ 
0 
0 
V1 Quantity 
(mL) (ng) 
0.4 40 
0.4 80 
0.4 120 
f 
20 40 
V2 C2 PCF Average 
(mL) (ng/mL) Recovery Rate (%) 
0.2 200 2 47± 11 
0.2 400 2 43±5 
0.2 600 2 70±5 
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Figure 4.20: Recovery Rate of atRA from Aqueous Solution and Analysed by 
HPLC-UV Using a Non-Buffered Mobile Phase ACN:H20 :HOAc (95:4 .99 :0.01 , v/v) 
with Low Flow Rate (0 .2 mL/min) . HPLC Pump: Waters, model 2695 Separation 
Column : Phenomenex Luna Cl8(2) (3 µm , 100 mm x 4.6 mm ID) . 
--
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Table 4.9: atRA Extraction Parameters for Analysis by HPLC-ESI-MS/MS Using 
ACN:H20:HOAc (95:4.99:0.01, v/v) . 
C1 V1 Quantity V2 C2 PCF Average 
(ng/mL) (mL) (ng) (mL) (ng/mL) Recovery Rate 
(%) 
25 0.4 10 0.2 50 2 35±34 
50 0.4 20 0.2 100 2 57±32 
75 0.4 30 0.2 150 2 80±36 
100 0.4 40 0.2 200 2 75±32 
200 0.4 80 0.2 400 2 64±9 
120 
100 
~ 
af 80 _. 
C\S 
i:i::: 
è 60 -
Il) t 
> 
0 40 () Il) 
~ 
20 
0 ·····························-r· ··r 
0 20 40 60 80 
atRA Quantity, ng 
Figure 4.21: atRA Recovery Rate from Aqueous Solution and Analysed by HPLC-
ESI-MS/MS at a Low Flow Rate 0.2 mL/min Using a Non-Buffered Mobile Phase 
ACN:H20:HOAc (95:4.99:0.01, v/v). HPLC Pump: Waters, Madel 2695 Separation 
Column: Phenomenex Luna C l 8(2) (3 µm , 100 mm x 4.6 mm ID). 
67 
~ Comparsion of atRA Recovery Rate Analysis by HPLC-UV and HPLC-ESI-
MS/MS Using a Non-Buffered Mobile Phase 
The conditions used in Figures 4.20 and 4.21 were applied to 40 and 80 ng of atRA 
and the results are compared in Figure 4.22. There are differences in extraction 
recovery rate when atRA is analysed by the two methods (HPLC-UV and HPLC-
ES I-MS/MS), for the same quantity of atRA and the same extraction proceture. The 
reason for these differences is not known. 
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Figure 4.22: Comparison of Extraction Recovery Rates of atRA by Different 
Analytical Methods (HPLC-UV and HPLC-ESI-MS/MS) for Different Quantities of 
atRA (40 and 80 ng), Using a Non-Buffered Mobile Phase ACN:H20:HOAc 
(95:4.99:0.01, v/v) . HPLC Pump: Waters Model 2695, Separation Column: 
Phenomenex Luna C18(2) (3 µm , 100 mm x 4.6 mm ID) and Flow Rate: 0.2 mL/min. 
It was found that the signal intensity is not stable in a non-buffered mobile phase. 
Figure 4.23 shows the fluctuations in signal intensity for standard solutions over 7 
days. 
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Figure 4.23: atRA Standard Solution Reproducibility Using a Non-Buffered Mobile 
Phase ACN:H20:HOAc (95:4.99:0.01 , v/v). HPLC Pump: Waters Mode! 2695, 
Separation Column: Phenomenex Luna Cl 8(2) (3 µm, 100 mm x 4.6 mm ID) and 
Flow Rate: 0.2 mL/min. 
As shown in Table 4.10, the signal intensity is not reproducible for standard solutions 
ranging from 50 to 200 ng/mL. A linear calibration curve was created from average 
data obtained in this concentration range. The coefficient of variation was 0.591 and 
slope of curve is equal 11426. There are significant differences between average 
observed areas and theoretically calculated areas of peaks using a high sensitivity 
method. The non-reproductibility of signal intensity of the standard solutions in a 
non-buffered mobile phase resulted in large standard deviations. 
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Table 4.10: Chromatographie Characteristics of atRA Standard Solutions Using a 
Mobile Phase of ACN:H20:HOAc (95:4.99:0.01 , v/v). 
Standard Average Obtained Peak Area Calculated Peak Area 
(ng/mL) (106) (106) 
50 1.3 ± 0.47 0.58 
75 0.47 ± 0.07 0.87 
100 1.5 ± 0.19 1.16 
150 1.06 ± 0.30 1.74 
200 2.73 ± 0.38 2.34 
In conclusion, a buffered mobile phase should be used to achieve a good 
reproductibility for both standard and extracted atRA solutions if high sensitivity is 
desired. 
• Assay with Buffered Mobile Phase 
~ HPLC 
•!• Mobile Phase Optimization 
Mobile phase optimization is extremely important for chromatography. Solvent 
selection is experimentally based which can be very time consuming when applied to 
complex media. The main objective of mobile phase optimization is to meet the 
following requirements: 
./ Determination the best retention time. It is preferable to elute atRA later than 
other polar metabolites in reverse phase so as to maintain sensitivity . 
./ Determining the best separation selectivity while balancing sensitivity. 
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In our case, more systematic strategies were needed. Retention time and selectivity 
may be optimized by changing mobile phase composition. The following parameters 
affect the sensitivity and selectivity and must be optimized 
o The mobile phase flow rate. 
o The type of organic sol vent (MeOH vs ACN). 
o The proportion of the organic portion of the mobile phase. 
o The type and concentration of buffer. 
o The type and proportion of aqueous buffer in the mobile phase 
o The eluent acidity when dealing with ionisable analytes like atRA 
MeOH was initially used as the organic sol vent in the development of the HPLC-UV 
method for the following reasons: 
o MeOH elutes analytes at lower retention time, therefore, it is more efficient 
for method development. 
o MeOH is a less toxic and a more enviromentally friendly solvent than ACN. 
o MeOH is less expensive than ACN. 
o MeOH decreases the risks of buffer precipitation in the mobile phase. 
Sorne limitations associated with the use of MeOH as the organic solvent are as 
follows: 
o The back-pressure for MeOH increases when mixed with water, thus, using a 
column with a low back-pressure is recommended. At the same flow rate, 
ACN-based solutions produce lower pressures in the column. 
o The flow rate of the organic solvent should be set lower with MeOH and 
higher with ACN. 
o UV absorption of MeOH is larger than for ACN. 
o The viscosity of MeOH is higher than that of ACN, thus, the pressure applied 
on the column by MeOH: H20 is higher than that of ACN: H20 (Aburjai, 
2011). 
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ACN was chosen as the best organic solvent for HPLC-UV method development for 
the following reasons: 
o ACN provides better resolution for many compounds by forming hydrogen 
bonds which result in better selectivity. 
o ACN has a higher ionisation strength than MeOH. 
o ACN offers reasonable buffer solubility. 
o ACN is 100% miscible with water. 
o ACN is transparent to UV light and offers a lower cutoff than MeOH. 
o ACN is able to form dipole-dipole type interactions. 
Different compositions of the mobile phase were investigated during development as 
shown in Table 4.11 
Table 4.11: Composition of Mobile Phase Study for Method Development. 
Organic Buffer Buffer Flow Demostrated 
Sol vent Type (M) pH O.P a A. p b Rate Method 
Type %v/v % v/v mL/min 
MeOH H20 - - 85 15 1.5 HPLC-UV 
HPLC-FLU 
MeOH NaOAc 0.01 5.2 80 20 1.5 HPLC-UV 
HPLC-FLU 
MeOH NaOAc 0.01 5.2 85 15 1.5 HPLC-UV 
HPLC-FLU 
MeOH NaOAc 0.01 5.2 90 10 1.5 HPLC-UV 
MeOH NaOAc 0.01 5.2 95 5 1.5 HPLC-UV 
MeOH NaOAc 0.1 5.2 95 5 1.5 HPLC-UV 
MeOH NH40Ac 0.1 5.2 95 5 0.2 HPLC-UV 
HPLC-ESI-MS/MS 
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MeOH NH40Ac 
ACN NH40Ac 
ACN NH40Ac 
ACN H20 
a: O. P: Organic Portion. 
b: A. P: Aqueous Portion 
0.15 
0.1 
0.15 
-
5.2 95 5 0.2 HPLC-UV 
HPLC-ESI-MS/MS 
5.2 95 5 0.2 HPLC-UV 
HPLC-ESI-MS/MS 
5.2 95 5 0.2 HPLC-UV 
HPLC-ESI-MS/MS 
- 95 5 0.2 HPLC-UV 
HPLC-ESI-MS/MS 
•:• Effect of Proportion of Buffer in the Mobile Phase on Sensitivity. 
To study the effect of the proportion of buffer in the mobile phase on sensitivity and 
retention time, a solution of 1 µg/mL of atRA was dissolved in MeOH to with two 
different volumes of buffer (MeOH: NH40Ac, O.OlM, 90:10 v/v; MeOH: NH40Ac, 
O.OlM; 80:20, v/v) were added. The data are summarized in Table 4.12 and the 
chromatograms obtained are shown in Figure 4.24. atRA elutes later with MeOH: 
NH40Ac 0.1 M (80:20, v/v) than with Me0H:NH40Ac 0.1 M (90: 10, v/v) using the 
same stationary phase and flow rate. The results demonstrate that the buffer 
composition of the mobile phase does not significantly affect the intensity of the 
signais but it does have an effect on the retention tirne for atRA. 
Table 4.12 Chromatographie Characteristics Obtained for atRA Eluted With MeOH: 
NH40Ac O.O l M (80:20, v/v) versus MeOH: NH40Ac O.OlM (90: 10, v/v) Using a 
Waters X-Terra MS Column 
Mobile Phase Composition Are a Height RT(min) 
MeOH: NH40Ac O.OlM (90:10, v/v) 5796 74 8 
MeOH: NH40Ac O.OlM (80:20, v/v) 5967 63 11 
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Figure 4.24: Comparison of Chromatograms of 1 µglmL atRA Analysed by HPLC-
UV Eluted With Me0H:NH40Ac O.OlM (80:20, v/v) vs Me0H:NH40Ac O.OlM 
(90:10, v/v). HPLC Pump: Spectra P4000, UV Detector: Waters 2487, Separation 
Column: Waters X-Terra MS Cl8 (2.5 µm , 50mm x 4.60 mm ID). 
•:• Effect of Different Types of Organic Portion of Mobile Phase on Sensitivity 
and on Signal Shape 
To determine the effect of the type of mobile phase on the sensitivity and retention 
times, two organic solvents (ACN vs MeOH) in the same proportions were used for 
the same stationary phase. The same flow rate was employed for both. As shown in 
Table 4.13 and Figure 4.25 , the results demonstrate that, with ACN, atRA elutes later 
than with MeOH and the atRA was detected with a reasonable signal intensity. 
Furthermore, the chromatogram obtained using MeOH shows two peak. Therefore, 
ACN was chosen as the organic solvent for the mobile phase as it better corresponds 
to ideal mobile phase characteristics. 
Table 4.13: Chromatographie Characteristics Obtained for atRA Eluted with ACN: 
NH40Ac O.OIM (95:5 , v/v) vs MeOH: NH40Ac O.OIM (95:5 , v/v) Using a Waters X-
Terra MS Cl 8 Column. 
Mobile Phase Composition 
Me0H:NH40Ac 0.01 M (95 :5, v/v) 
ACN:NH40Ac O.OIM (95:5, v/v) 
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Figure 4.25: Chromatograms for Comparison of 1 µg/mL atRA Solution Eluted with 
Mobile Phase ACN:NH40Ac O.OlM (95:5 , v/v) vs Me0H:NH40Ac O.OlM (95:5, 
v/v) . HPLC Pump: Waters 590, UV Detector: Waters 2487, Separation Column: 
Waters X-Terra MS C18 (2.5 µm , 50 mm x 4.60 mm ID) and flow Rate: 0.2 mL/min. 
--------- ------------------ - ---------------------
Final Mobile Phase Selection 
The concentration of atRA used for the sample was 1 µg/mL while the retention 
times, peak areas and peak heights of two different mobile phases were compared. 
From the data shown in Table 4.14 and the chromatograms are shown in Figure 4.26, 
the following observations were made: 
• The signal observed for MeOH:NH40Ac O. lM (95:5, v/v) is more intense 
than that found for ACN:NH40Ac O. lM (95:5, v/v). 
• The retention time for MeOH:NH40Ac O. lM (95:5, v/v) was less than that for 
ACN:NH40Ac0.1M (95:5, v/v). 
• The concentration of buffer had a small effect on signal intensity and retenti on 
time. 
Table 4.14: Chromatographie Data for 4 Different Compositions of Mobile Phase. 
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Mobile phase Peak Area Peak Height RT (min) 
A MeOH:NH40Ac O.lM (95:5, v/v) 6383 160 8 
B MeOH:NH40Ac 0.15M (95:5, v/v) 6959 173 8 
c ACN:NH40Ac O.lM (95:5, v/v) 6591 98 16 
D ACN:NH40Ac 0.15M (95:5, v/v) 5650 92 19 
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Figure 4.26: atRA Chromatograms Obtained for the 4 Mobile Phases Listed in Table 
4.14. HPLC Pump: Waters 590, UV Detector: Waters 2487, Separation Column: 
Phenomenex Kinetex Cl8 (2.6 µm, 150 mm x 4.60 mm ID) and Flow Rate: 0.2 
ml/min. 
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Although the mobile phase containing MeOH is more sensitive for the elution of 
atRA than is that containing ACN, its retention time in the MeOH mobile phase is 
less than that for the mobile phase made up of ACN. A longer elution time (16 min), 
and thus the mobile phase with ACN, is preferred in order to avoid undesired 
interferences from more polar compounds present in physiological media; which are 
anticipated to elute earlier. Thus ACN:NH40Ac O. lM (95 :5, v/v) better meets the 
method development objectives and so was the chosen mobile phase. 
./ Stationary Phase Characterization 
Stationary phase characterization began using five different columns: the Thermo 
Hypersil, the Waters X-Terra, Phenomenex Luna and kinetex columns. The Luna had 
a P/D of 5µm and the another of 3µm. The effect of length and, more particularly the 
diameter, on sensitivity and retention time was studied for the quantification of atRA 
at pharmacological concentrations. Two main factors were considered for the trace 
level analysis of atRA: resolution and sensitivity which both play critical roles in 
stationary phase performance. Resolution is the result of three factors , which include 
selectivity, retention and efficiency. Among these parameters, the column selectivity 
has the most impact and thus should be focus of method development. 
Column selectivity depends on the following factors: hydrophobicity, steric 
interaction and the ability to form and break hydrogen bonds. 
Among these factors , steric interaction is the most important for product analysis 
since the retinoids undergo a cis-trans isomerization. Sensitivity, that is, the signal-to-
noise ratio, is related to concentration and depends upon parameters such as 
efficiency, injection volume, column length, column internai diameter and capacity 
factor (Phenomenex, 2013 ). Table 4.15 shows the stationary phase portion of the 
method development. 
Table 4.15: Stationary Phases Studied for Method Development. 
Brand Name Manufacturer Mode! P/D (µm) Dimension (mm) 
Phenomenex Luna Cl 8 (2) 5 l 50 x4.6 
Thermo Scientific Hypersil Gold 3 50x2.5 
Waters X-Terra MS C18 2.5 50x4.6 
Phenomenex Kinetex C18 2.6 100x4.6 
Phenomenex Luna c 18 (2) 3 1 OO x4.6 
P/D: Particular Diameter 
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•!• Effect of Column Length on Sensitivity, Signal Shape and Retention Time of 
atRA. 
As shown in Table 4.16 and Figure 4.27, the signal intensities and retention tünes 
with two Cl8 columns (the Phenomenex Kinetex and the Waters X-Terra MS 
Cl8) were compared using a solution of atRA in MeOH (1 µg /mL) eluted with 
MeOH:NH40Ac 0.1 M (95:5, v/v) . The solid line represents atRA eluted from 
the Phenomenex Kinetex column while the red one represents atRA eluted from 
the Waters X-Terra. The main difference between these columns is the column 
length and atRA elutes at 7 min from the X-Terra and 14 min from the Kinetex 
respectively. In addition, a very intense peak which was observed at 6 min on the 
Kinetex stationary phase was absent from the X-Terra one. The use of the Kinetex 
column resulted in a better signal shape in comparison to that of the X-Terra one. 
In addition, no significant difference in the signal sensitivity was found between 
the two columns. 
Table 4.16: Chromatographie Information ofTwo Different Cl 8 Columns 
Phenomenex Kinetex and Waters X-Terra MS Using Mobile Phase MeOH: NH40Ac 
O. l M (95:5, v/v). 
Column Peak Area Peak Height RT(min) 
Phenomenex Kinetex 2320 30 14 
Waters X-Terra 2255 37 7 
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Figure 4.27: Comparison of Signal Shapes and Retention Time Using MeOH: 
NH40Ac 0.1 M (95:5 , v/v) for a solution of atRA on Two Cl8 Columns, i.e. the 
Phenomenex Kinetex and theWaters X-Terra MS. 
Another test was performed with ACN: NH40Ac 0.1 M (95:5 , v/v) as the mobile 
phase and same two columns as above. The atRA eluted at retention time of 11 .6 and 
18.1 min, respectively. Again, there was no significant difference in the signal 
intensities. 
Final Stationary Phase Selection 
Based on the physical characteristics, the Phenomenex Kinetex column, with core 
shell particles, was chosen as the best stationary phase for atRA method 
development. The reasons were as follows: 
o lt is a stationary phase with a high steric interactions and it is the best suited 
for the separation of conformational isomers (cis-trans). 
o lt offers a high hydrophobicity, which favors stronger retention of these 
compounds. 
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o It offers a decreased internai diameter and smaller particle s1ze which 
improves the sensitivity of the analysis. 
o It allows for rapid analysis and for an increased mobile phase flow rate 
without loss of analytical performance. 
o It offers high particle density and an optimal bed structure. This reduces band 
broadening effects of eddy diffusion allows for faster mass transfer 
o It has a porous layer (shell), which decreases the diffusion path length, 
therefore reducing the time it takes for molecules to diffuse in and out of a 
particle. 
During the last stage of method development, a problem of bacteria precipitation 
occurred. Therefore, the whole chromatographie system was replaced with new 
chromatographie material. The Phenomenex Kinetex C 18 column (2.6 ~Lm , 1 OO 
mm x 4.60 mm ID) separation column was replaced by a Phenomenex Luna 
C18(2) column (3 µm, 100 mm x 4.6 mm ID). The new column, while not 
identical, has very similar in properties as compared to the fonner. 
•!• Desorption Solution Selection. 
In order to choose a proper desorption solvent, a solution of 1 µg/mL of atRA in 
MeOH was prepared in four different desorption solutions which are listed in the 
Table 4.17 and injected to the system using ACN:NH40Ac (O. lM, 95 :5, v/v) as 
mobile phase. According to the chromatograms shown in Figure 4.28 and data 
presented in Table 4.17, the desorption solution of ACN:NH40Ac 0.15M (95:5 , v/v) 
shows the greatest peak surface area and highest peak. Therefore, it was selected as 
the desorption solution to analyse extracts of atRA. 
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Table 4.17: atRA Desorption Solutions Chromatographie Data. 
Desorption Solutions Peak Area Peak Height RT(min) 
A 
B 
c 
D 
MeOH:NH40Ac O.lM (95:5, v/v) 
MeOH:NH40Ac 0.15M (95:5, v/v) 
ACN:NH40Ac O.lM (95 :5, v/v) 
ACN:NH40Ac 0.15M (95:5 v/v) 
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Figure 4.28: atRA Chromatograms Obtained for the 4 Different Desorption 
Solutions listed in Table 4.17 Using Mobile Phase ACN: NH40Ac O. lM (95:5, v/v). 
HPLC Pump: Waters 590, UV Detector: Waters 2487, Separation Column: 
Phenomenex Kinetex (2 .6 µm, 150 mm x 4.60 mm ID) and Flow Rate: 0.2 mL/min. 
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~ Extraction of atRA with EtOAc:Acidified Hexanes and Analysis by HPLC-
ESI-MS/MS Using Buffered Mobile Phase 
As mentioned previously, HCl ( 4N, 0.90 %, v/v) was chosen for the acidification of 
hexanes but some undesired effects were observed with subsequent analysis in non-
buffered mobile phase. It was decided to change the acid from HCl (4N, 0.90%, v/v) 
to glacial HOAc (0 .25, v/v) . The same extraction protocol was used and the effect of 
each acid on the recovery rate was evaluated by HPLC-ESI-MS/MS using a buffered 
mobile phase, as shown in Figure 4.29. The extraction protocol using HCI (4N) 
proved to be less reproducible than that using glacial HOAc for quantities of atRA 
from 10 to 80 ng. The recovery rate does not change significantly except for the 
lowest quantity of atRA (i.e., 10 ng). In this case, extraction with HCl (4N) showed a 
higher recovery rate. 
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Figure 4.29: Comparison of Recovery Rates Obtained from Extraction of 10, 20 and 
80 ng of atRA From a 0.4 mL Aqueous Solution Using EtOAc:Acidified Hexanes 
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(50:50, v/v) with HCl 4N or Glacial HOAc. HPLC Pump: Waters 2695, Mobile 
Phase: ACN:NH40Ac (0.1 M, 95:5, v/v), Separation Column: Phenomenex Luna 
Cl 8(2) (3 µm, 1 OO mm x 4.6 mm ID) and Flow Rate: 0.2 mL/min. 
•!• Effect of the Quantity of Glacial HO Ac in Hexanes on Extraction Profile 
As mentioned before, glacial HOAc was chosen for the acidification of the hexanes 
extraction solvent. As showed in Figure 4.30, the chromatographie profiles for 
extracts of 20 ng quantity of atRA using EtOAc: acidified hexanes (50:50, v/v) with 
HOAc (0.25 % v/v, red) and (0.12% v/v, black). The chromatogram of HOAc 0.25% 
v/v shows a negative peak that appears at 20 min that is at the tail end of atRA peak. 
This peak is not observed with HOAc of 0.12% v/v. Thus, HOAc (0.12% v/v in 
hexanes) was chosen in the final extraction protocol. 
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Figure 4.30: Comparison of Chromatograms Obtained for Extractions of 20 ng of 
atRA Using 0.12% v/v vs 0.25% v/v of glacial Acetic Acid in Hex:EtOAc (50:50, 
v/v) as Organic Extraction Solvents. HPLC Pump: Waters 2695 , Mobile Phase: 
ACN:NH40Ac O.lM (95:5 , v/v). Separation Column: Phenomenex Luna Cl 8(2) (3 
µm, 1 OO mm x 4.6 mm ID) and Flow Rate: 0.2 mL/min. 
~ Comparsion of atRA Extracts Analysed by HPLC-ESI-MS/MS Using 
Buffered and Non-Buffered Mobile Phase 
The extraction recovery rates for atRA detennined by HPLC-ESI-MS/MS using non-
buffered and buffered mobile phases are compared in Figure 4.31 . The results show 
no significant variations in the extraction recovery rates but there was significant 
differences in reproductibility between using the non-buffered and buffered mobile 
phases. The buffered mobile phase offers better reproductibility for both standard and 
extraction solutions of atRA. 
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Figure 4.31 : Comparison of Extraction Recovery Rates of atRA Determined by 
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HPLC-ESI-MS/MS Using Buffered and Non-Buffered Mobile Phases. HPLC Pump: 
Waters 2695, Separation Colurnn: Phenomenex Luna C18 (2) (3 µm , lOOmm x 4.6 
mm ID) and Flow Rate: 0.2 mL/min. 
);> Optimized Extraction Conditions for atRA analysis 
After each parameter had been optimized and the final conditions established, they 
were used for all subsequent analyses, as presented in chapter 5. 
1- The hexanes was acidified with glacial H OAc (0.12% v/v) . 
2- The mixed extraction solvent was EtOAc: Acidified Hexanes (1.3 mL, 50:50, 
v/v). 
3- The desorption solution was ACN: NH40Ac 0.15 M (95:5 , v/v). 
4- The buffered mobile phase used was ACN: NH40Ac 0.1 M (95:5 , v/v). 
5- The mobile phase flow rate was 0.2 mL/min. 
•:• Optimized Extraction Protocol 
1- A atRA mother solution (10 µg/mL in MeOH) was freshly prepared on the day of 
the analyses by diluting a stock solution warmed to room temperature before use. 
2- Aqueous solutions containing atRA were prepared from the mother solution and 
0.4 mL of each solution was transferred to a glass tube. 
3- HPLC MeOH (0.4 mL) was then added to each tube. 
4- Organic extraction solvents: EtOAc:Acidified Hexanes (1.3 mL, 50:50 v/v) 
contaning glacial HOAc (0.12 v/v) was added to the solution. 
5- The mixture was stirred for 5 min at the speed of 5000 RPM. 
6- The upper organic phase was transfered to a glass test tube and evaporated almost 
to dryness under a gentle stream of nitrogen gas. 
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7- The extraction was perfonned three times, with the third extraction including 
acidified hexanes (1.3 mL). 
8- The three extracts were combined and evaporated to dryness at room temperature 
under a gentle stream of nitrogen gas. 
9- The residue was dissolved in 200 µL of desorption solution ACN :NH40Ac O. l 5M 
(95:5 ,v/v). 
10- The final extracted solution was filtered on a 0.45 µm fil ter before injection. 
11 - 20 µL was injected into the reverse phase HPLC system. 
~ Summary of Method Development Optimization 
It was found that the MS/MS signal for a non-buffered mobile phase was more 
sensitive and the specific ion was more abundant than that for the buffered one. 
Moreover, the non-buffered mobile phase can prevent proliferation and precipitation 
of in the whole chromatographie system since bacterial growth is encouraged by the 
presence of ammonium acetate in the buffered mobile phase ACN :NH40Ac 0.1 M 
(95:5 , v/v) . Quantitative MS/MS assays were performed with a non-buffered mobile 
phase. Optimization was investigated using different volumetric amount of acid, that 
is, ACN:H20:HOAc in the following proportions : 1) 95:4.80:0.20; 2) 95:4.90:0.10, 
v/v and 3) 95:4.99:0.01 , v/v. The non-buffered mobile phase was chosen to be 
ACN:H20:HOAc (95:4.99 :0.01 , v/v) because it increases the signal intensity for both 
the standard and extraction solutions of atRA. The first analysis and extraction 
optimization assay using the above mobile phase were performed with HCl (4N) in 
different proportions ranging from 0.3 to 0.9 % v/v. Finally HCl ( 4N, 0.9 % v/v) was 
found to gi ve the highest extraction recovery rate. Therefore, this proportion was 
chosen to acidify the hexanes. Unfortunately, the standard deviation obtained for the 
MS/MS analyses of the standard and extracted solutions were quite high. This 
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behaviour was not observed with UV detection indicating that the non-buffered 
mobile phase could be causing variability in the MS/MS signal. 
In order to obtain a reproducible MS/MS signal, a buffered mobile phase is needed. 
Therefore, method optimization for atRA analysis was continued using the standard 
solution with ACN:NH40Ac 0.1 M (95:5 , v/v) as the mobile phase and UV detection. 
The data shows that this system followed by desorption with ACN: NH40Ac 0.15 M 
(95:5, v/v) was the best choice for obtaining the greatest signal. For atRA extraction, 
HOAc (0.12%, v/v) was chosen to acidify the organic solvents. Thus the method 
described offers the optimum conditions for high sensitivity. 
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CHAPTER V 
RESULTS AND DISCUSSION 
The results and discussion section is divided into two major parts: 
The first one covers the quantification and comparison of analytical parameters for 
diffèrent techniques (HPLC-UV, HPLC-FLU and HPLC-ESI-MS/MS) used during 
the early and final stages of method development. It also includes detennination of 
the limit of detection (LOD), and quantification (LOQ), the linearity range and the 
coefficient of variation (R2). 
The second part focuses on the study of extracted atRA analysis by HPLC-UV and 
HPLC-ESI-MS/MS. It includes determination of: the range of recovery rates, the 
standard deviation, the minimum detectable amount and any matrix effects on atRA 
analysis (that is, aqueous vs serum-supplemented cell culture media aMEM: FBS 
(90: 10, v/v) and their influences on final method development. 
5.1 atRA Analytical Parameters ofHPLC-UV, HPLC-FLU and HPLC-ESI-
MS/MS. 
As shown in the early method development section in Chapter IV, atRA analysis was 
starts with aqueous media using a buffered mobile phase MeOH:NaOAc, O.OlM 
(85:15, v/v) at a high flow rate (1.5 mL/min). Figure 5.1 presents the variation in 
atRA peak area obtained using a UV or a FLU detector for concentrations ranging 
from 75 to 1000 ng/mL. Calibration curves were generated by analysing 4 
concentrations from which best fit line were detennined by least squares regression. 
Peaks were identified on the bases of their retention times. atRA standards for each 
analysis were freshly prepared on the day of the run by dilution of the mother 
solution. Linear calibration curves were obtained, giving a slope of 0.1016 and a 
coefficient of variation (R2) of 0.9 127 for HPLC-FLU and a slope of 0.5483 and a R2 
of 0.9974 for HPLC-UV. 
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Figure 5.1: Comparison of atRA Standard Calibration Curves Analysed by HPLC-
UV and HPLC-FLU. HPLC Pump: Spectra Model P4000, Mobile Phase: 
MeOH:NaOAc O.OlM (85: 15 , v/v). Separation Column: Phenomenex Luna Cl 8(2) (5 
µm, 150 mm x 4.6 mm ID) and a Flow Rate of 1.5 mL/min. 
The sensitivity of both methods is best visualized in Figure 5.2, for which both 
chromatograms were obtained from the analysis of the same solution of atRA ( 1 OO 
ng/mL in mobile phase) using HPLC-UV (black) and HPLC-FLU (red) . The greater 
sensitivity of the HPLC-UV method is clearly visible. 
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Figure 5.2: Comparative Sensitivities of HPLC-UV vs HPLC-FLU for the Analysis 
of a Solution of atRA in Mobile Phase (100 ng/mL). HPLC Pump: Spectra Model 
P4000; Mobile Phase: MeOH:NaOAc O.OlM (85:15 , v/v) . Separation Column: 
Phenomenex Luna Cl 8(2) (5 µm , 150 mm x 4.6 mm lD) and a Flow Rate: 1.5 
mL/min. 
Based on the data shown in Fig. 5.2, the LOD and LOQ for both the HPLC-UV and 
the HPLC-FLU methods were determined. Their values are shown in Table 5.1. The 
LOD is defined using S/N=3 while the LOQ is defined using S/N= l 0 with both being 
expressed as ng/mL (ppb) . The LOD were 7 for HPLC-UV and 24 for HPLC-FLU, 
respectively. Thus, HPLC-UV detection is three times more sensitive in aqueous 
media. From this point onwards, HPLC-UV was the detector used for method 
development. 
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Table 5.1: Comparison of Analytical Parameters for HPLC-UV and HPLC-FLU. 
Analytical Parameters SIN HPLC-UV HPLC-FLU 
LOD (ng/mL) 3 7 24 
LOQ (ng/mL) 10 23 80 
The final step of method development for the analysis of atRA was carried out using 
a HPLC-ESI-MS/MS at a low flow rate (0.2 mL/min). The composition of the mobile 
phase was changed from MeOH:NaOAc O.OlM, (80: 15 , v/v) to ACN:NH40Ac O. lM, 
(95:5 v/v) and a HPLC-UV was used to monitor the behaviour of the HPLC-ESI-
MS/MS . Standard calibration curves of atRA were generated by analyzing separately, 
5 concentrations of standard solution ranging from 75 to 550 ng/mL. Figures 5.3 and 
5.4 show the standard calibration curves obtained by HPLC-UV and by HPLC-ESI-
MS/MS of fresh atRA. Their coefficent of variation was found to be greater than 
0.999. The sensitivities of the methods were compared at a reduced eluent flow rate 
using a volatile buffer in the mobile phase. 
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Figure 5.3: atRA Standard Calibration Curve Analysed by HPLC-UV 
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HPLC Pump: Waters 590, Mobile Phase: ACN:NH40Ac O. lM (95:5 , v/v), 
Separation Column Phenomenex Kinetex Cl 8, and Flow Rate: 0.2 mL/min. 
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Figure 5.4: atRA Standard Calibration Curve Analysed by HPLC-ESI-MS/MS. 
HPLC Pump: Waters 590, Mobile Phase: ACN:NH40Ac O.lM (95:5 v/v), Separation 
Column Phenomenex Kinetex C 18 and Flow Rate: 0.2 mL/min. 
Figure 5.5 shows two chromatograms for the analysis of a same solution of atRA 
(75 ng/mL) by HPLC-UV (left) and by HPLC-ESI-MS-MS (right). lt can clearly be 
seen that, while both traces have a similar signal intensity, the latter chromatogram 
has less noise. 
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Figure 5.5 : Sensitivity of HPLC-UV vs HPLC-ESI-MS/MS Analysis of an atRA 
Standard Solution (75 ng/mL) . HPLC Pump: Waters 590, Mobile Phase: 
ACN:NH40Ac 0.1 M (95:5, v/v). Separation Column: Phenomenex Luna and Flow 
Rate: 0.2 mL/min. 
The analytical parameters are summerized in Table 5.2 and show that detection using 
a HPLC-ESI-MS/MS is ten times more sensitive than that using a HPLC-UV. 
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Table 5.2: Comparison of Analytical Parameters for HPLC-UV and HPLC-ESI-
MS/MS. 
Analytical Parameters LOD RL Linearity Range 
(ng/mL) (ng/mL) 
HPLC-UV 10 0.9988 75-550 
HPLC-ESI-MS/MS 1 0.9973 5-550 
The LOD of atRA obtained by HPLC-UV using MeOH:NaOAc (0.01 M) as the 
mobile phase at 1.5 mL/min (1 OO ng/mL) as shown in Table 5.1 , was comparable to 
that obtained from ACN:NH40Ac 0.1 M (95:5 , v/v) at 0.2 mL/min; which indicates 
that the LOD is independent of the nature of the mobile phase and flow rate. 
5.2 Recovery Rate of atRA Extracted in Aqueous and Serum-Supplemented Cell 
Culture Media 
The extraction of atRA was performed in triplicate for each experiment and the 
recovery rates presented in Tables and Figures in this section are averages . 
5.2.1 Analysis of atRA Extracts in Aqueous Media 
The extraction of atRA was performed for quantities ranging from 20 to 120 ng in 
aqueous medium using a HPLC-UV. The average recovery rates are shown in Table 
5.3 and Figure 5.6. The results show an average recovery rate of 72±4 % which 
demonstrates the reliability of the extraction method. 
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Table 5.3: atRA Extraction Recovery Rate m Aqueous Media Obtained Using 
HPLC-UV Analysis. 
Quantity MRR a 
(ng) (%) 
20 72±7 
30 73±5 
50 58±2 
60 86±6 
120 64±3 
a: Mean Recovery Rate± SD for three analysis. 
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Figure 5.6: Analysis of Extracted in Aqueous Media by HPLC-UV at a Low Flow 
Rate. HPLC Pump: Waters 590, UV Detector: Waters 2487, Mobile Phase: 
ACN:NH40Ac 0.1 M (95:5 , v/v), Separation Column: Phenomenex Luna Cl 8(2) (3 
µm, 1 OO mm x4.6 mm ID) and Flow Rate: 0.2 mL/min. 
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For HPLC-ESI-MS/MS, atRA extractions were performed for quantities rangmg 
from 5 to 80 ng and the recovery rate results are presented in Table 5.4 and Figure 
5.7. The results show a constant recovery rate of 35% over the range from 5 to 10 ng 
which increases to 54% for quantities from 20 to 80 ng. The low standard deviation 
observed indicates the reliability of the extraction protocol using a HPLC-ESI-
MS/MS. Similar deviations were found using a HPLC-UV. The standard deviation of 
± 10 % for 40 ng may be attributed to manipulation errors during the extractions. 
Table 5.4: atRA Extraction Recovery Rate m Aqueous Media Obtained Using 
HPLC-ESI-MS/MS Analysis. 
Quantity MRR % 
(ng) 
5 34±3 
10 36±1 
20 59±4 
40 59± 10 
80 45±2 
97 
100 
80 
~ 0 
af 
....... 60 Cil ~ 
è f 
Q) 40 -> 
• 0 + (.) 
Q) 
~ 20 
0 
0 20 40 60 80 
atRA Quantity, ng 
Figure 5.7: atRA Recovery Rate in Aqueous Media Analysed by HPLC-ESI-
MS/MS. HPLC Pump: Waters 2695, Mobile Phase: ACN:NH40Ac 0.1 M (95:5 , v/v), 
Separation Column: Phenomenex Luna C18(2) (3 µm , 100 mm x 4.6 mm ID) and 
Flow Rate: 0.2 mL/min. 
•!• Comparsion the Recovery Rates of atRA Extracted from Aqueous Medium 
Analysed by HPLC-UV and HPLC-ESI-MS/MS 
Table 5.5 summerizes the extraction recovery rates obtained using HPLC-UV and 
HPLC-ESI-MS/MS for atRA quantities ranging from 5 to 120 ng. For the HPLC-UV, 
the extraction started at 20 ng (for an analyte concentration of 1 OO ng/mL) due to the 
limitation of detection for this instrument. The low recovery rates for 5 and 10 ng 
observed using the HPLC-ESI-MS/MS can be explained by a loss of some atRA 
during sample preparation. Therefore these values were discarded. As shown in Table 
5.5, a difference in mean recovery rates (MRR) for the two methods was observed; 
the MRR of HPLC-UV was 30% higher than that of HPLC-ESI-MS/MS which 
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reflects real behavior. lt is possible that this is due to the presence of acetic acid, used 
during the extraction process, since this acid is known to suppress the MS/MS signal. 
Depending on how the extracted product is evaporated, a small residual amount of 
acetic acid may be present in the extracted atRA (Table 5.5). Hence during HPLC-
ESI-MS/MS analysis, the presence of acetic acid could cause atRA ion suppression 
resulting in a lower signal (Antignac et al., 2005 ; Lee and Volmer, 2006). This 
behavior was not observed when HPLC-UV was used. To confirm whether the 
presence of acetic acid is causing a lower signal. The extracted atRA should be dried 
for a longer time so as to more completely remove any remaining acetic acid in the 
sample. A study of the effect of presence of acetic acid, used to acidify the hexanes 
on atRA recovery rate might be worthwhile. 
Table 5.5: Comparsion of atRA Recovery Rates from Aqueous Media Obtained 
Using HPLC-UV and HPLC-ESI-MS/MS. 
atRA Detection Method 
Quantity HPLC-UV HPLC-ESI-MS/MS 
(ng) 
5 - 34±3 
10 - 36±1 
20 72±7 59±4 
30 73±5 -
40 - 59± 10 
50 58±2 -
60 86±6 -
80 - 45±2 
120 64±3 -
MRR 72±5 54±5 
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5.2.2 Analysis of atRA Extracted From Serum-Supplemented Cell Culture Media 
aMEME:FBS (90: 10, v/v) 
Table 5.6 shows the experimental recovery rate of atRA extracted from serum-
supplemented cell culture media. Because of the limited availability of this medium, 
the volume of serum was not as consistent as for the aqueous extractions. Therefore 
its volume was reduced from 0.4 to 0.3 mL. Consequently, the pre-concentration 
factors were 1.5 and 2 for the extractions carried out with 0.3 mL and 0.4 mL, 
respecti vel y. 
Table 5.6: atRA Recovery Rate from Serum-Supplemented Cell Culture Media 
aMEM:FBS (90:10, v/v) Obtained by HPLC-UV Analysis . 
Quantity ARR 
(ng) (%) 
50 60±3 
60 72±1 
90 75± 10 
100 85±4 
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Figure 5.8: atRA Analysis of Extract in Serum-Supplemented Cel! Culture Media 
aMEM:FBS (90:10, v/v) ; HPLC Pump: Waters 2695 , Mobile Phase: ACN: NH40Ac 
(0.1 M, 95:5 , v/v) and Desorption Solution: ACN:NH40Ac 0.15 M (95:5 , v/v) 
Separation Colurnn: Phenomenex Luna Cl 8 (2) and Flow Rate: 0.2 mL/min. 
•:• Comparison of atRA Extracted From Aqueous and Serum-Supplemented Cell 
Culture Media Analysed by HPLC-UV 
The data from the analysis of atRA extracts, as shown in Figures 5.6 and 5.8, were 
compared in quantities ranging from 20 to 120 ng and from 50 to 1 OO ng in aqueous 
and serum-supplemented media, respectively. Because of the limited availibility of 
the serum, atRA quantities below 50 ng were not analysed. The results demonstrate 
that there was no matrix effect nor was there any co-eluting interference observed for 
the analysis of extracted atRA. 
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Table 5.7: Comparsion of atRA Extract Recovery Rates from Aqueous and Serum-
Supplemented Culture Media aMEM:FBS (90:10, v/v) Obtained by HPLC-UV. 
Analysis . 
Recovery Rate From 
Quantity Aqueous Medium Serum-Supplemented Cell Culture Medium 
(ng) (%) (%) 
20 64±7 -
30 64±5 -
50 - 60±3 
60 86±2 72±5 
80 73±6 -
90 - 75±10 
100 - 85±4 
120 72±3 -
MRR 72±5 73±6 
5.3 Comparison of Our Methods vs Other Validated Assays 
It is difficult to compare the results of this method with the others because some of 
the analytical parameters, such as: the type of instrument, the chromatographie 
conditions, the separation modes, the extraction protocol , the injection volume and 
the type of media analysed were quite different from other, reported assays. Table 5.9 
summarizes a comparison of various parameters derived from our methods (UQAM) 
with those from other validated methods. These parameters includes: the detection 
method, the limit of detection (LOD), the detected quantity limit and the extraction 
recovery rates (ERR) for analysis of atRA from different matrices. 
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Table 5.8: Comparison of Ours vs. Other Validated Analytical Methods. 
Methods Author Detection Method LOD Tested MRR Matri ces Analysed 
Quantity % 
(ng) 
(Bérnbe et al. , 201 0) HPLC-UY 10 20 72±5 Nano pure Water 
(ng/mL) (Aqueous) 
(Bérnbe et al. , 20 10) HPLC-UV 10 50 73±6 Serum Supplemented 
(ng/mL) Cell Culture Media 
HPLC-ESI-MS/MS 1 (ng/mL) 
(Bérnbe et al. , 20 10) 133 5 54±5 Nano pure water 
(finol) (Aqueous) 
(Wu el al. , 20 IO) VPLC- ESl-MS/MS 20 Not 59 Influent, Effluent, 
(ng/mL) Reported Ri ver and Sea Water 
(Kane et al., 2008) HPLC-APCI -MS/M S 0.625 Not 80± 11 to Mouse Serum and 
(fin ol) Reported 95±4 Ti ssue 
(Ruhl , 2006) 0.2 Not 89 Serum and Cell 
HPLC-APC I-MS/MS (ng/mL) Reported 
(Kane et al., 2005) HPLC-APC l-MS/MS 0. 15 0.3 80±4 Serum, Tissue 
(ng/mL) 
Note: The extraction recovery rate for our method was calculated by comparing of 
the peak areas of atRA obtained for an extracted vs. a standard solutions ( extemal 
method) while the other validated methods used an internai standard in the extract 
solutions. 
5.4 Advantages of Our Methods 
};;> These methods allow for extracted atRA in aqueous or serum-supplemented 
cell media to be analysed in a single run by HPLC-UV or HPLC-ESI-MS/MS . 
};;> These methods are applicable to the quantification of atRA at both 
pharmacological and physiological levels. 
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);> These methods offer a desirable flat baseline in both aqueous and cell culture 
media. 
);> The analysis can be carried out using different buffered mobile phase (ACN-
or MeOH) at a high or low flow rate. 
);> An aqueous, buffered mobile phase was chosen to max1m1ze atRA ion 
generation when ESI-MS/MS detection is used since this leads to good 
reproducibility of signal intensity for the standard and extracted solutions. 
);> LLE is an inexpensive, simple and time efficient way to extract atRA from 
the desired media (aqueous or serum) and offers protocol efficiency over a 
specific range. 
);> The extraction protocol was optimized for interference suppression of the 
atRA peak area as well as address minimization of ion suppression in ESI-
MS/MS. 
);> These methods offer a reasonable standard deviation for the extracted atRA 
solution. 
5.5 Disadvantages of Analytical Methods 
);> The extraction recovery rate was determined by the comparison of the area 
and height of the atRA peak vs that of a standard solution which offers less 
accuracy than an interna! standard in the atRA to be extracted. 
CHAPTER VI 
CONCLUSION 
This study focused on the development of analytical methods for the quantification of 
atRA in pharmacological level (µg) and physiological levels (ng) by HPLC-UV and 
HPLC-ESI-MS/MS in aqueous and serum-supplemented cell culture media 
aMEM:FBS (90: 10, v/v). atRA is a light sensitive compound which easily isomerizes 
upon exposure to light. We demonstrated that the highly sensitive and selective 
HPLC-ESI-MS/MS was an efficient technique for the quantification of atRA at very 
low concentrations. Since atRA is ionisable, it is important to contrai mobile phase 
pH so as to obtain a high signal intensity. In this study, non-buffered and buffered 
mobile phases were studied. The use of a buffered mobile phase allowed for the 
generation of a parent ion at m/z 299 for [atRA-Hr with relatively good signal 
stability and reproducibility. The use of a non-buffered mobile phase resulted in the 
formation of an abundant fragment ion at m/z 255 for [atRA-C02L but the signais 
were not sufficiently reproducible for either the standard or extracted solutions. A 
serious limitation associated with the use of a buffered mobile phase is bacterial 
growth in the chromatographie system. Thus, a protocol was developed to avoid this 
problem. Tandem mass spectroscopy in ion filtering mode offered a better signal-to-
noise ratio and, therefore, a better detection limit for atRA. The LODs for the HPLC-
UV and HPLC-FLU at a high flow rate (l .5mL/min) with a mobile a phase of 
MeOH:NaOAc O.OlM (85 :15, v/v) were 7 and 24 ng/mL, respectively, for aqueous 
solutions. The HPLC-UV was found to be three times more sensitive than HPLC-
FLU in aqueous media. However, at lower flow rate (0 .2 mL/min) and with the 
mobile phase ACN:NH40Ac O.lM (95:5 , v/v) as the mobile phase, the LOD for the 
HPLC-UV was found to be 10 ng/mL; while HPLC-ESI-MS/MS method was 1 
ng/mL. That is, this method is ten times more sensitive than is the HPLC-UV. The 
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type and proportion of acid, used for acidification of organic extraction solvent 
(hexanes) was an important parameter in the extraction protocol affecting both the 
recovery rate and chromatogram profile. Liquid-Liquid extraction and analysis by 
HPLC-ESI-MS/MS permitted the quantification of 5 ng of atRA in aqueous media 
with a 34% recovery rate, white at 50 ng, the sample extracted from the serum-
supplemented cell culture media could be analysed by HPLC-UV with a with 60% 
recovery rate. 
CHAPTER VII 
PERSPECTIVES 
As mentioned in the introduction, the realisation of this project was planned to have 
in two phases. The first phase was the analysis of atRA in vitro aqueous, serum-
supplemented cell culture media aMEM:FBS (90: 10, v/v) and the second phase was 
its analysis in vivo (P19 embryonic stem cell cultures). Due to time limitations, atRA 
analysis focused on the in vitro and remain to be validated in vivo. Because of severe 
sample volume limitations of the P 19 embryonic stem cell culture medium, the 
following should also be investigated: 
);>- A study of the scope and limitations of our method for the analysis of atRA 
metabolites. 
);>- An optimization of instrumental parameters (ion source and analyser) to have 
sufficiently abundant specific ions derived from atRA and the other 
metabolites in stem cell extracts and culture media. 
);>- An optimization of the extraction protocol to achieve the highest recovery rate 
at very low possible quantity of analytes. 
);>- A study of the effect of the mobile phase · buffer iomc strength on ion 
suppression and signal intensity. 
);>- A study of the effects of ion-pairing contaminants on the electrospray signal. 
Suppression of atRA and metabolites present in cell culture media based on 
literature for other analytes (Holcapek et al., 2004). 
);>- A study of the scope and limitations of our method for the analysis of other 
available synthetic retinoids (such as E19, E23) which are not light sensitive 
and can be used for application in modeling cell growth. 
);>- A study of atRA and other metabolites stabilities in stem cell culture media. 
(Sharow, Temkin and Asson-Batres, 2012) 
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APPENDIXA 
Developed Protocol for Quantification of atRA usmg a HPLC Waters 2695 
Separation Module. 
Sol vent Management for the Analysis of atRA by HPLC-2695 Separation Module 
1. Remove old mobile phase from reservoirs A and B (if B was used with 
buffer) and replace them with Pure Water. 
2. Select 100% A and then, direct function then wet prime for at least 2 
minutes at 7.5 mL/ min if the pressure is not stable abort wet prime and 
perform dry prime. 
3. Draw the solvent from the bottle and close the valve by pressing cancel. 
4. Repeat the wet prime from reservoir A until the pressure is stable 
(2-3% fluctuations). 
5. Purge the injector with mobile phase ACN:NH40Ac: O. lM (95:5, v/v). 
6. Make sure that reservoirs C and D are filled with solvents 
(H20, MeOH or ACN). 
7. Select the appropriate mobile phase composition and perfonn direct 
function -pure injector. 
8. Make sure the seal wash inlet is in the water-enriched solution, go to menu 
screen (initial screen) and select diag seal wash. Check that the liquid 
flows properly in the tubing around the pump heads and abort. 
9. Make sure that the needle wash inlet is in the appropriate solution 
ACN:H20 (80:20, v/v). 
1 O. Go to menu screen (initial screen) select diag-needle wash. Let it finish on 
its own. Needle wash needs to be repeated if the solvent composition is 
changed. 
11. Switch the composition to the method's composition and start flowing it 
throw the column. 
12. Watch the pressure and make sure it has stabilized (2-3% fluctuations) 
13. Increase the flow at lmL with mobile phase. 
14. Condition the separation column at flow rate of lmL for 30 min with 
mobile phase. 
15. Select the appropriate instrument method and monitor the baseline until it 
stabilized the system is ready for injections. 
At the end of Analysis 
16. Perform needle, injector and seal wash with (MeOH 100%). 
17. Recondition the separation column at lmL/min flow rate for 30 min with 
ACN:H20 (50:50, v/v) 
18. Press stop and tum offHPLC module. 
Important note : 
);;;:- Algae and bacteria can grow in aqueous mobile phase, especially in the 
pH 4-8 range, replace buffers on the regular basis ( every 2 days is a 
good practice). 
);;;:- Always use amber clean bottles for storing buffers and aqueous mobile 
phases. 
);;;:- Depending on their buffering capacity, buffers are very likely to absorb 
C02 and induce a pH change. Protection of the mobile phase against 
pH change can be done by flushing an inert gas in it and the using an 
ascarite trap . 
);;;:- Ammonium acetate is particularly hydroscopic thus it should be used 
freshly prepared and stored immediately in a desiccator. 
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APPENDIXB 
Mass and Composition of Cell Culture Media (Catalog No. 310-011 lX Liquid 
aMEM). 
Amino Acids Con CAS M.W Formula 
(g mor1) 
(mg/L) 
L-Alanine 25 .00 56-41-7 89.09 C3H7N02 
L-Arginine-HCI 126.50 1119-34-2 210.66 C6H14N4Ü2 
L-Asparagine-H20 50.00 70-47-3 132.11 C4HsN20 3 
L-Aspartic Acid 30.00 617-45-8 133.10 C4H4NÜ4 
L-Cysteine HCl-H20 100.00 7048-04-6 175 .6 C3H1N02S.HCl.H20 
L-Cystine-2HCI 31.20 30925-07-6 313.22 C6H1 2N20 4S2.2HCI 
L-Glutamic acid 75.00 56-86-0 147.13 H02CCH2CH2CH(NH2)C02H 
L-Glutamine 292.00 56-85-9 146.14 H2NCOCH2CH2CH(NH2)C02H 
Glycine 50.00 56-40-6 75.07 NH2CH2COOH 
L-Histidine-HCl-H20 41.90 71-00-1 155 .15 C6H9N3Ü2 
L-Iso leucine 52.50 73-32-5 13 l. l 7 C2HsCH(CH3)CH(NH2)C02H 
L-Leucine 52.50 6 1-90-5 131.17 ( CH3)2CH CH2CH(NH2)C02H 
L-Lysine-HCI 72.50 10098-89-2 182.65 C6H14N20 2.HCI 
L-Methionine 15.00 63-68-3 149.21 CH3SCH2CH2CH(NH2)C02H 
L-Phenylalanine 32.50 63-91-2 165.19 C6HsCH2CH(NH2)C02H 
L-Proline 40.00 147-85- 13 115.13 C5H9N02 
L-Serine 25.00 56-45-1 105.09 HOCH2CH(NH2)C02H 
L-Threonine 47.60 72-19-5 119.12 CH3CH(OH)CH(NH2)C02H 
L-T yrosine.2N a-2H20 51.90 - - -
L-T ryptophan IO.OO 73-22-3 204.23 C11H12N20 2 
L-Valine 46.80 72-18-4 117. 15 (CH3)2CHCH(NH2)C02H 
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Vitamins Con CAS M.W Formula 
(mg/mL) (g mor') 
Ascorbic Acid 50.00 50-81-7 176.2 C6Hs0 6 
D-Calsium pantothenate 1.00 - - -
Bio tin 0.10 58-85-5 244.31 C10H16N203S 
Choline chloride 1.00 67-48-1 139.62 (CH3)3NCH2CH20H 
Folie acid 1.00 59-30-3 441.40 C19H19N106 
Nicotinamide 1.00 98-92-0 122.12 C6H6N20 
Pyridoxine-HCI 1.00 58-56-0 205.64 CsH11N03.HCI 
Riboflamin 0.10 83-88-5 376.36 C11H20N406 
T-Diamine HCI 1.00 67-03-8 337.27 C12H 17CIN40S.HCI 
Vitamin Bl2 1.36 68-19-9 1355.3 C63HssCON 14014P 
D-Glucose 1000.0 50-99-7 180.16 C6H1 20 6 
Lipoid acid 0.20 1200-22-2 206.33 CsH1 4Ü2S2 
Sodium pyruvate 110.00 113-24-6 110.4 CH3COCOONa 
Nucleosides Con CAS M.W Formula 
(mg/mL) (g mor') 
Thymidine IO.OO 50-89-5 242.23 C10H14N20 s 
Adenosine IO.OO 58-61-7 267.24 C10HnNsÜ4 
Cytidine 10.00 65-46-3 243.22 C9H13N30 5 
Guanosine IO .OO 118-00-3 283.24 C10HnNsOs 
2-Deoxycytidine-HCI 11.00 3992-45-5 263 .68 C9H13N30 4.HCI 
2-Deoxyguanosine IO.OO 312693-74-4 285.26 C10H 13N504.H20 
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